<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6338361</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0007017</article-id><article-id pub-id-type="publisher-id">PNTD-D-18-00838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Toxicology</subject><subj-group><subject>Toxic Agents</subject><subj-group><subject>Toxins</subject><subj-group><subject>Venoms</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Toxicology</subject><subj-group><subject>Toxic Agents</subject><subj-group><subject>Toxins</subject><subj-group><subject>Venoms</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Edema</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Edema</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Reptiles</subject><subj-group><subject>Squamates</subject><subj-group><subject>Snakes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Antigens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Antigens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antigens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antigens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antigens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Proteases</subject><subj-group><subject>Serine Proteases</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Proteases</subject><subj-group><subject>Serine Proteases</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Animal Studies</subject><subj-group><subject>Experimental Organism Systems</subject><subj-group><subject>Model Organisms</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Model Organisms</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Animal Studies</subject><subj-group><subject>Experimental Organism Systems</subject><subj-group><subject>Animal Models</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Dogs</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><italic>Naja annulifera</italic> Snake: New insights into the venom components and pathogenesis of envenomation</article-title><alt-title alt-title-type="running-head"><italic>N</italic>. <italic>annulifera</italic> snake: Venom components and pathogenesis of envenomation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Silva-de-Fran&#x000e7;a</surname><given-names>Felipe</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Villas-Boas</surname><given-names>Isadora Maria</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Solange Maria de Toledo</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cogliati</surname><given-names>Bruno</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chudzinski</surname><given-names>Sonia Aparecida de Andrade</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Priscila Hess</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kitano</surname><given-names>Eduardo Shigueo</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Cinthya Kimori</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1896-9074</contrib-id><name><surname>Tambourgi</surname><given-names>Denise V.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Immunochemistry Laboratory, Butantan Institute, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Special Laboratory of Applied Toxinology, Butantan Institute, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Pathology, School of Veterinary Medicine and Animal Science, University of S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Casewell</surname><given-names>Nicholas R.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Liverpool School of Tropical Medicine, UNITED KINGDOM</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>denise.tambourgi@butantan.gov.br</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2019</year></pub-date><volume>13</volume><issue>1</issue><elocation-id>e0007017</elocation-id><history><date date-type="received"><day>24</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Silva-de-Fran&#x000e7;a et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Silva-de-Fran&#x000e7;a et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0007017.pdf"/><abstract><sec id="sec001"><title>Background</title><p><italic>Naja annulifera</italic> is a medically important venomous snake occurring in some of the countries in Sub-Saharan Africa. Accidental bites result in severe coagulation disturbances, systemic inflammation and heart damage, as reported in dogs, and death, by respiratory arrest, in humans. Despite the medical importance of <italic>N</italic>. <italic>annulifera</italic>, little is known about its venom composition and the pathogenesis of envenomation. In this paper, the toxic, inflammatory and immunogenic properties of <italic>N</italic>. <italic>annulifera</italic> venom were analyzed.</p></sec><sec id="sec002"><title>Methodology/Principal findings</title><p>Venom proteomic analysis identified 79 different proteins, including Three Finger Toxins, Cysteine Rich Secretory Proteins, Metalloproteinases, Phospholipases A<sub>2</sub> (PLA<sub>2</sub>), Hyaluronidase, L-amino-acid oxidase, Cobra Venom Factor and Serine Proteinase. The presence of PLA<sub>2</sub>, hyaluronidase, fibrinogenolytic and anticoagulant activities was detected using functional assays. The venom was cytotoxic to human keratinocytes. In an experimental murine model of envenomation, it was found that the venom induced local changes, such as swelling, which was controlled by anti-inflammatory drugs. Moreover, the venom caused death, which was preceded by systemic inflammation and pulmonary hemorrhage. The venom was shown to be immunogenic, inducing a strong humoral immune response, with the production of antibodies able to recognize venom components with high molecular weight and to neutralize its lethal activity.</p></sec><sec id="sec003"><title>Conclusions/Significance</title><p>The results obtained in this study demonstrate that <italic>N</italic>. <italic>annulifera</italic> venom contains toxins able to induce local and systemic inflammation, which can contribute to lung damage and death. Moreover, the venom is immunogenic, an important feature that must be considered during the production of a therapeutic anti-<italic>N</italic>. <italic>annulifera</italic> antivenom.</p></sec></abstract><abstract abstract-type="summary"><title>Author summary</title><p><italic>N</italic>. <italic>annulifera</italic> is a dangerous snake that belongs to the Elapidae family. It is found in some of the countries in Sub-Saharan Africa and has caused accidents in humans and dogs. In this study, we characterized some of the biochemical, toxic and immunogenic properties of <italic>N</italic>. <italic>annulifera</italic> venom. We showed that the venom is composed of several proteins, some of which display enzymatic activities, such as phospholipase A2, hyaluronidase, metalloproteinases and serine proteinases. The venom promoted disturbances in the human coagulation system and was cytotoxic to human epidermal cells. Using a mouse model, we showed that the venom promotes local reactions that were reduced with anti-inflammatory drugs. The venom caused systemic inflammation, lung hemorrhage and death. Further, the venom stimulated production of high antibody titers when injected into mice and the antiserum produced was able to inhibit venom-induced death. This study demonstrated that <italic>N</italic>. <italic>annulifera</italic> venom contains toxins that trigger inflammatory process, which may contribute to the envenomation pathology. Moreover, the venom is immunogenic, an important aspect for the production of an efficient <italic>N</italic>. <italic>annulifera</italic> antivenom.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</institution></institution-wrap></funding-source><award-id>2013/07467-1</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1896-9074</contrib-id><name><surname>Tambourgi</surname><given-names>Denise V.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003593</institution-id><institution>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico</institution></institution-wrap></funding-source><award-id>301358/2017-6</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1896-9074</contrib-id><name><surname>Tambourgi</surname><given-names>Denise V.</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by research grants from FAPESP (2013/07467-1 - Center of Toxins Immune-Response and Cell Signalling - CeTICS), CNPq (301358/2017-6) and CAPES.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="27"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p>Envenoming from snakebites is a public health problem in rural areas of the tropical and subtropical countries in Africa, Latin America, Asia and Oceania [<xref rid="pntd.0007017.ref001" ref-type="bibr">1</xref>, <xref rid="pntd.0007017.ref002" ref-type="bibr">2</xref>]. This medical condition kills more than 95,000 people per year and leads over 300,000 victims to live with permanent sequelae [<xref rid="pntd.0007017.ref003" ref-type="bibr">3</xref>].</p><p>It is also estimated that there are approximately 3,700 species of snakes worldwide [<xref rid="pntd.0007017.ref004" ref-type="bibr">4</xref>]. Of these, approximately 15% are venomous and have caused serious accidents involving humans and other animals [<xref rid="pntd.0007017.ref005" ref-type="bibr">5</xref>]. Venomous snakes belong to the Colubroidea superfamily, which is composed of several families, such as Colubridae, Viperidae, Lamprophiidae and Elapidae [<xref rid="pntd.0007017.ref006" ref-type="bibr">6</xref>, <xref rid="pntd.0007017.ref007" ref-type="bibr">7</xref>]. The Elapidae family consists of 61 genera and includes 365 species [<xref rid="pntd.0007017.ref008" ref-type="bibr">8</xref>], which are distributed in the tropical and temperate regions of Africa, America, Asia and Australia. These snakes can live in terrestrial or aquatic environments and present variable diet, including small vertebrates, such as birds, rodents, reptiles and fishes or invertebrates [<xref rid="pntd.0007017.ref009" ref-type="bibr">9</xref>, <xref rid="pntd.0007017.ref010" ref-type="bibr">10</xref>].</p><p>The venom of Elapidae is well known to contain powerful neurotoxins that play a role in the snake defense against predators and prey capture. These neurotoxins may also be responsible for some of the clinical manifestations observed in human envenomation, such as respiratory arrest [<xref rid="pntd.0007017.ref011" ref-type="bibr">11</xref>, <xref rid="pntd.0007017.ref012" ref-type="bibr">12</xref>]. However, several studies have noted the presence of different components in these venoms, including phospholipases A<sub>2</sub> (PLA<sub>2</sub>), hyaluronidases (HYA) [<xref rid="pntd.0007017.ref013" ref-type="bibr">13</xref>, <xref rid="pntd.0007017.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0007017.ref015" ref-type="bibr">15</xref>], metallo- (SVMP) and serine proteinases (SVSP) [<xref rid="pntd.0007017.ref016" ref-type="bibr">16</xref>, <xref rid="pntd.0007017.ref017" ref-type="bibr">17</xref>, <xref rid="pntd.0007017.ref018" ref-type="bibr">18</xref>], inhibitors [<xref rid="pntd.0007017.ref019" ref-type="bibr">19</xref>], peptides [<xref rid="pntd.0007017.ref020" ref-type="bibr">20</xref>] and cytotoxins [<xref rid="pntd.0007017.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0007017.ref022" ref-type="bibr">22</xref>]. All of these components may have cytotoxic [<xref rid="pntd.0007017.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0007017.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0007017.ref024" ref-type="bibr">24</xref>], hemorrhagic, anticoagulant [<xref rid="pntd.0007017.ref025" ref-type="bibr">25</xref>], pro-inflammatory [<xref rid="pntd.0007017.ref026" ref-type="bibr">26</xref>, <xref rid="pntd.0007017.ref027" ref-type="bibr">27</xref>] or immunogenic [<xref rid="pntd.0007017.ref028" ref-type="bibr">28</xref>] properties.</p><p>The genus Naja presents specimens that cause a large and serious number of accidents [<xref rid="pntd.0007017.ref003" ref-type="bibr">3</xref>, <xref rid="pntd.0007017.ref008" ref-type="bibr">8</xref>, <xref rid="pntd.0007017.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0007017.ref029" ref-type="bibr">29</xref>]. One dangerous representative of this genus is <italic>Naja annulifera</italic>, which is popularly called the Banded or Snouted Cobra [<xref rid="pntd.0007017.ref030" ref-type="bibr">30</xref>, <xref rid="pntd.0007017.ref031" ref-type="bibr">31</xref>]. It is found in Sub-Saharan Africa countries, including Zambia, Malawi, Mozambique, Swaziland, Zimbabwe, Botswana and South Africa, in savannah grasslands, deserts, and rocky areas and near human habitations. This ranging of habits is associated to its broad diet, once it feeds on frogs, lizards, birds and it eggs, snakes and rats.</p><p>Accidents involving <italic>N</italic>. <italic>annulifera</italic> are considered severe. The envenomed individuals experience swelling, pain and local burning at the site of the bite, followed by pain throughout their entire body. Beside these clinical findings, affected individuals can present with dizziness and palpebral ptosis. Some can progress to respiratory arrest and, without a specific treatment, death. The treatment for envenomated individuals is serum therapy and in respiratory arrest cases, mechanical ventilation. Some studies have also reported that envenomed individuals in South Africa may develop necrosis at the site of the bite as well as hematologic disturbances [<xref rid="pntd.0007017.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0007017.ref031" ref-type="bibr">31</xref>, <xref rid="pntd.0007017.ref032" ref-type="bibr">32</xref>, <xref rid="pntd.0007017.ref033" ref-type="bibr">33</xref>].</p><p>Veterinary epidemiologic data demonstrated that approximately 60% of dogs poisoned by snakebites in South Africa were bitten by <italic>N</italic>. <italic>annulifera</italic>. These dogs presented with various clinical findings, including hematologic alterations, such as leukocytosis and thrombocytopenia [<xref rid="pntd.0007017.ref034" ref-type="bibr">34</xref>], increased plasma levels of Cardiac Troponin I and C Reactive Protein (CRP) [<xref rid="pntd.0007017.ref035" ref-type="bibr">35</xref>] and disturbances in the coagulation system [<xref rid="pntd.0007017.ref036" ref-type="bibr">36</xref>].</p><p>Information about the components of <italic>N</italic>. <italic>annulifera</italic> venom is scarce. Some authors have noted the presence of several cyto/cardiotoxins and neurotoxins [<xref rid="pntd.0007017.ref037" ref-type="bibr">37</xref>, <xref rid="pntd.0007017.ref038" ref-type="bibr">38</xref>, <xref rid="pntd.0007017.ref039" ref-type="bibr">39</xref>, <xref rid="pntd.0007017.ref040" ref-type="bibr">40</xref>, <xref rid="pntd.0007017.ref041" ref-type="bibr">41</xref>, <xref rid="pntd.0007017.ref042" ref-type="bibr">42</xref>]. Despite its medical importance, epidemiologic, clinical and experimental studies of <italic>N</italic>. <italic>annulifera</italic> venom are limited and the mechanisms by which it causes toxicity remains poorly understood. The goal of the present study was therefore to describe the components of <italic>N</italic>. <italic>annulifera</italic> venom and its toxic activities, utilizing <italic>in vitro</italic> and <italic>in vivo</italic> models to better understand the pathology of envenomation by this snake.</p></sec><sec sec-type="materials|methods" id="sec005"><title>Methods</title><sec id="sec006"><title>Reagents</title><p>Bovine serum albumin (BSA), Concanavalin A from <italic>Canavalia ensiforms</italic> (ConA), Wheat Germ Agglutinin from <italic>Triticutun vulgaris</italic> (WGA), Tween 20, Triton X-100, 3&#x02019;3&#x02019;-Diaminobenzidine (DAB), Hyaluronic Acid, anti-mouse IgG horseradish labeled with Peroxidase (IgG-HRPO), Ortho-phenylenediamine (OPD), cetyltrimethylammonium bromide (CTAB), Gelatin, Comassie Brilliant Blue R-250, Human Fibrinogen (Fb), Human Thrombin, 1,10 Phenantroline (1,10 Phe), Phenylmethasulfonyl Fluoride (PMSF), Dimethyl Sulfoxide (DMSO), Cromolyn, Dexamethasone, Trypsin, Solid Phase Extraction Disks (SDB-XC membranes), Hepes, urea, iodoacetamide and trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich (Missouri, USA). The Bicinchoninic Acid (BCA) Protein Assay Kit was purchased from Pierce Biotechnology, Inc. (Wisconsin, USA). SDS-PAGE (Amersham ECL Gel 8&#x02013;16%, 10 wells) gels were obtained from GE Healthcare Life Sciences (Uppsala, Sweden). Dithiothreitol (DTT) was from Calbiochem (Darmstadt, Germany). The nitrocellulose membrane and EnzChek Phospholipase A2 Assay Kit were purchased from Thermo Fisher Scientific (Massachusetts, USA). Aluminum Hydroxide (Al(OH)<sub>3</sub>) was purchased from Prati Donaduzzi (Sao Paulo, Brazil). Anti-mouse IgG labeled with alkaline phosphatase (IgG-AP), Nitroblue Tetrazolium chloride (NBT), 5-bromo-4-chloro-3-indolyl-phosphatase (BCIP) and CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit were obtained from Promega Corp. (Madison, Wisconsin, USA). ELISA plates were purchased from Costar Corning, Inc. (New York, USA). Calcium chloride, Cephalin and Thromboplastin were obtained from Stago (Saint-Quen-I&#x02019;Aum&#x000f4;ne, France). Indomethacin, MK-886 (Sodium Salt) and WEB-2086 were purchased from Cayman Chemical (Michigan, USA). The BD Cytometric Bead Array (CBA) Mouse Inflammation and Mouse IL-1&#x003b2; ELISA kits were obtained from BD Biosciences (New Jersey, USA). The mouse IL-17 DuoSet3.2.4.3 ELISA kit was obtained from R&#x00026;D Systems (Minnesota, USA). The Pan&#x000f3;tico R&#x000e1;pido kit was purchased from Laborclin (Parana, Brazil). The HaCat human keratinocyte lineage was obtained from the Rio de Janeiro Cell Bank (Rio de Janeiro, Brazil). Dulbecco's Modified Medium Eagle&#x02014;Gibco (DMEM) medium, penicillin and streptomycin were purchased from Invitrogen Corp. (California, USA). Fetal Bovine Serum was obtained from Cultilab (S&#x000e3;o Paulo, Brazil). 3-(4,5-dimethylthiazol-2-yl)2,5-di-phenyltetrazolium bromide (MTT) was obtained from Merk (Darmstadt, Germany). Frits for SPE cartridges were obtained from Agilent (California, USA) 10 &#x003bc;m Jupiter C-18 beads were purchased from Phenomenex (Torrance, USA). 3 &#x003bc;m ReproSil-Pur C-18 beads were obtained from Dr. Maisch (Ammerbuch, Germany). 75 &#x003bc;m I.D. or 100 &#x003bc;m I.D. x 360 &#x003bc;m O.D. polyimide coated capillary tubing were purchased from Molex (Lisle, USA).</p></sec><sec id="sec007"><title>Venoms</title><p><italic>N</italic>. <italic>annulifera</italic> venom (South Africa specimens) was purchased from Latoxan Natural Active Ingredients (Valence, France). The lyophilized venom was reconstituted in sterile saline solution at 5 mg/mL. The protein content was assessed with the BCA Protein Assay Kit according to the manufacturer&#x02019;s recommendations. The samples were aliquoted and stored at -80&#x000b0;C until use. <italic>Bothrops jararaca</italic>, <italic>Crotalus durissus terrificus</italic> and <italic>Tityus serrulatus</italic> venoms were supplied by Butantan Institute, SP, Brazil, and their use was approved by the Brazilian Institute of Environment and Renewable Resources (IBAMA), an enforcement agency of the Brazilian Ministry of the Environment (protocol number: 010035/2015-0), and by SisGen (Sistema Nacional do Patrim&#x000f4;nio Gen&#x000e9;tico e do Conhecimento Tradicional Associado (protocol numbers AD50761 and AEE9AEA).</p></sec><sec id="sec008"><title>Ethics statement</title><p>High<sub>III</sub> (H<sub>III</sub>) female mice weighing 18&#x02013;22 g were obtained from the Immunogenetics laboratory, while Balb/c male mice weighing 18&#x02013;22 g were obtained from the Center for Animal Breeding, both from Butantan Institute. All procedures involving animals were in accordance with the ethical principles for animal research adopted by the Brazilian Society of Animal Science and the National Brazilian Legislation n&#x000b0;.11.794/08. The protocols used in the present study were approved by the Institutional Animal Care and Use Committee of the Butantan Institute (protocols approved n&#x000b0; 01092/13 and 01262/14).</p><p>Experiments using samples obtained from humans were previously approved by the Human Research Ethics Committee of the Municipal Health Secretary of S&#x000e3;o Paulo. Human blood samples were obtained from healthy donors who knew of the purposes of this study and signed the corresponding informed consent form (protocol approved n&#x000b0; 974.312).</p></sec><sec id="sec009"><title>Characterization of the components of <italic>N</italic>. <italic>annulifera</italic> venom</title><sec id="sec010"><title>Electrophoresis and lectin Western blot</title><p>Samples of <italic>N</italic>. <italic>annulifera</italic> venom (15 &#x003bc;g) were separated by SDS-PAGE on 8&#x02013;16% or 12% gels [<xref rid="pntd.0007017.ref043" ref-type="bibr">43</xref>], under reducing or non-reducing conditions, and were silver stained [<xref rid="pntd.0007017.ref044" ref-type="bibr">44</xref>] or blotted on nitrocellulose membranes [<xref rid="pntd.0007017.ref045" ref-type="bibr">45</xref>]. After the transfer, the membranes were blocked with 5% BSA in Phosphate Buffered Saline (PBS) (8.1 mM sodium phosphate, 1.5 mM potassium phosphate, 137 mM sodium chloride and 2.7 potassium chloride, p.H. 7.2) and then incubated with peroxidase labeled lectins, ConA (1:1000 dilution) or WGA (1:2000 dilution) to detect residues of Mannose and N-acetylglucosamine [<xref rid="pntd.0007017.ref046" ref-type="bibr">46</xref>]. Glycosylated proteins were detected using a solution that contained 0.1% hydrogen peroxide plus 0.5 mg/mL DAB.</p></sec><sec id="sec011"><title>Mass spectrometric protein identification</title><p>For the proteomic analysis, <italic>N</italic>. <italic>annulifera</italic> venom was submitted to trypsin digestion as described by Kinter and Sherman [<xref rid="pntd.0007017.ref047" ref-type="bibr">47</xref>]. Briefly, 200 &#x003bc;g venom (three replicates) were denatured with 6 M urea in 100 mM Tris-HCl, pH 8, and reduced with dithiothreitol (DTT) 10 mM for 1 h at room temperature. Cysteine carbamidomethylation was performed by incubation with iodoacetamide 40 mM for 1 h at room temperature, followed by addition of DTT 40 mM to consume excess of alkylating agent. Protein samples were diluted with water until the concentration of urea decreased to about 0.7 M and trypsin was added using an enzyme: substrate ratio of 1:50 (w/w) at 37&#x000b0;C for 18 h. The reaction was stopped with 20% TFA until pH 3 and desalting was carried out by loading individual samples to p-1000 StageTip SDB-XC [<xref rid="pntd.0007017.ref048" ref-type="bibr">48</xref>]. After drying using a vacuum centrifuge, peptide mixtures were dissolved in 100 &#x003bc;L of 0.1% formic acid (solution A) and peptide concentration was estimated. For that, a peptide standard curve was prepared using a mixture of trypsin-digested bovine serum albumin (MassPREP BSA Digestion Standard; Waters) ranging from 0.2 to 1.2 &#x003bc;g/&#x003bc;L (in solution A). The absorbance was measured at 214 nm using a NanoDrop spectrophotometer (Thermo Scientific), and peptide sample concentration was determined using the standard curve. For analysis, each peptide sample (5 &#x003bc;g) was automatically injected using an EASY Nano LCII system (Thermo Scientific) into a 5 cm of 10 &#x003bc;m Jupiter C-18 trap column (100 &#x003bc;m I.D. &#x000d7; 360 &#x003bc;m O.D.) coupled to an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). Chromatographic separation of tryptic peptides was performed on a 15-cm long column (75 &#x003bc;m I.D. x 360 &#x003bc;m O.D.) packed in-house with 3 &#x003bc;m ReproSil-Pur C-18 beads (Dr. Maisch, Germany). Peptides were eluted with a linear gradient of acetonitrile in 0.1% formic acid (solution B) at 200 nL/min: the linear step used for the elution was 5&#x02013;35% in 75 min. Spray voltage was set at 2.2 kV and the mass spectrometer was operated in data dependent mode, in which one full MS scan was acquired in the m/z range of 300&#x02013;1,600 followed by MS/MS acquisition using collision induced dissociation of the ten most intense ions from the MS scan. MS spectra were acquired in the Orbitrap analyzer at 30,000 resolution (at 400 m/z) whereas the MS/MS scans were acquired in the linear ion trap. The minimum signal threshold to trigger fragmentation event, isolation window, activation time and normalized collision energy were set to, respectively, 1,000 cps, 2 m/z, 10 ms and 35%. A dynamic peak exclusion (list size of 500) was applied to avoid the same m/z of being selected for the next 20 seconds. Two independent LC-MS/MS runs were performed for each sample.</p></sec><sec id="sec012"><title>Database search</title><p>Protein identification was performed using the MaxQuant software suite (v 1.5.3.12) [<xref rid="pntd.0007017.ref049" ref-type="bibr">49</xref>] using the theoretical trypsin fragments produced from the database restricted to the taxonomy &#x0201c;Serpentes&#x0201d; (Uniprot release September 14, 2016; 63,114 sequences). The database search considered the precursor mass tolerance of 20 ppm, in the first search, and the nonlinear mass recalibration was made in the masses of first pass identifications. The second search considered the mass tolerance of 4.5 ppm and tolerance for fragments was set to 0.5 Da. The following search parameters were used: iodoacetamide derivatives of cysteine were considered as fixed modification, oxidation of methionine was specified as variable modification, and up to two missed cleavages by trypsin were accepted. Assignments for peptides and proteins were accepted at a false discovery rate &#x0003c; 1%. For the identification, only proteins identified in at least two experimental replicates, with at least 1 unique peptide and posterior error probability &#x02264; 0.01 were accepted. &#x0201c;Match between runs&#x0201d; feature was enabled. For each protein group in the MaxQuant&#x02019;s &#x02018;proteinGroups.txt&#x02019; file, the first protein entry was selected as representative. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (<ext-link ext-link-type="uri" xlink:href="http://proteomecentral.proteomexchange.org/">http://proteomecentral.proteomexchange.org</ext-link>), via the PRIDE partner repository [<xref rid="pntd.0007017.ref050" ref-type="bibr">50</xref>], with the dataset identifier: PXD010962 (Username: <email>reviewer27828@ebi.ac.uk</email>; Password: BNxFCLRG).</p></sec></sec><sec id="sec013"><title>Toxic-Enzymatic properties of the venom</title><sec id="sec014"><title>Gelatinolytic activity</title><p>The gelatinolytic activity of the <italic>N</italic>. <italic>annulifera</italic> snake venom was evaluated with zymography using gelatin as the substrate [<xref rid="pntd.0007017.ref051" ref-type="bibr">51</xref>]. Samples of the venom (30 &#x003bc;g), prepared under non-reducing conditions, were separated via 10% SDS-PAGE with 1 mg/ml gelatin. The gels were washed for 2 hours at room temperature in 2.5% Triton X-100 solution and incubated overnight at 37&#x000b0;C in substrate buffer (50 mM Tris-HCl, 200 mM NaCl, 10 mM CaCl<sub>2</sub>, 0.05% Brij-35, p.H. 8.3). After this period, the gels were stained with Coomassie Brilliant Blue solution (40% methanol, 10% acetic acid and 0.1% Coomassie Brilliant Blue).</p></sec><sec id="sec015"><title>Fibrinogen cleavage</title><p>Human fibrinogen samples (30 &#x003bc;g) were incubated with 5 &#x003bc;g of <italic>N</italic>. <italic>annulifera</italic> venom or saline for 1 hour at 37&#x000b0;C under constant agitation. In parallel, venom samples were pre-incubated with 1.10 Phe (10 mM) or PMSF (10 mM) at room temperature for 30 minutes. After incubation, the mixtures were submitted to SDS-PAGE using a 8&#x02013;16% gradient gel under reducing conditions and stained with Coomassie Brilliant Blue solution. The positive control of the reaction was human Thrombin (1U).</p></sec><sec id="sec016"><title>Hyaluronidase activity</title><p>Hyaluronidase activity was analyzed according to the methodology described by Purkrittayakamee et al. [<xref rid="pntd.0007017.ref052" ref-type="bibr">52</xref>] with slight modifications. Briefly, samples of <italic>N</italic>. <italic>annulifera</italic> venom (20 &#x003bc;g) were incubated with a mixture that contained hyaluronic acid (1 mg/mL) (100 &#x003bc;L) and acetate buffer (200 mM sodium acetate and 0.15 M of NaCl, p.H. 6.0) (400 &#x003bc;L) at 37&#x000b0;C for 15 minutes. After incubation, the reactions were stopped with 1 mL of CTAB (2.5% CTAB and 2% NaOH). The absorbances were measured at &#x003bb;405 nm in a spectrophotometer (Multiskan EX, Labsystems, Finland) against a blank that contained hyaluronic acid, acetate buffer and CTAB. The results are expressed as units of turbidity reduction (UTR) <italic>per</italic> mg of venom. <italic>T</italic>. <italic>serrulatus</italic> scorpion venom (20 &#x003bc;g) was used as a positive control.</p></sec><sec id="sec017"><title>PLA<sub>2</sub> activity</title><p>PLA<sub>2</sub> activity was evaluated using the EnzChek<sup>TM</sup> Phospholipase A2 Assay Kit according to the manufacturer&#x02019;s recommendations. Briefly, samples of <italic>N</italic>. <italic>annulifera</italic> venom (0.5 &#x003bc;g) was incubated with a phospholipid mix that contained 10 mM Dioleoylphosphatidylcholine and 10 mM Dioleoylphosphatidylglycerol in 96-well microtiter plates. Increased fluorescence was evaluated using a spectrometer FLUOstar Omega (BMG Labtech, Ortenberg, Germany) at &#x003bb;<sub>EM</sub> 460 and &#x003bb;<sub>EX</sub> 515 nm and 37&#x000b0;C for 10 minutes. Specific activity was expressed as Units of Fluorescence (UF) <italic>per</italic> minute <italic>per</italic> microgram of venom. <italic>C</italic>. <italic>d</italic>. <italic>terrificus</italic> (0.5 &#x003bc;g) venom was used as positive control.</p></sec><sec id="sec018"><title>Cytotoxic activity</title><p>The HaCat human keratinocyte cell lineage was cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37&#x000b0;C and 5% CO<sub>2</sub>. The action of <italic>N</italic>. <italic>annulifera</italic> venom on the viability of human keratinocytes was evaluated using the MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) method [<xref rid="pntd.0007017.ref053" ref-type="bibr">53</xref>] with minor modifications. Keratinocytes (5&#x000d7;10<sup>4</sup> cells/well) were grown in 96-well plates that contained supplemented DMEM medium and were then maintained for 24 hours in DMEM medium without SFB. After this period, cells were incubated for 72 hours in increasing venom concentrations at 37&#x000b0;C and 5% CO<sub>2</sub>. The supernatant from the wells was aspirated and 60 &#x003bc;l of the MTT solution (0.83 &#x003bc;g/&#x003bc;L) in incomplete DMEM medium was added to the wells. The plates were then incubated for 30 minutes at 37&#x000b0; C and 5% CO<sub>2</sub>. Thereafter, the supernatant was aspirated, 100 &#x003bc;L/well of DMSO was added, and the plates were allowed to stand at room temperature for five minutes. The spectrophotometric analysis of the reactions (Multiskan-EX, Labsystems, Helsinki, Finland) was performed at &#x003bb; 540 nm. Cell viability was calculated as: [O.D. experimental sample <sub>(540nm)</sub>*100]/[O.D. control sample<sub>(540nm)</sub>]. The results are expressed as cell viability (%).</p><p>Additionally, the action of <italic>N</italic>. <italic>annulifera</italic> venom on the viability of human keratinocytes was evaluated by Lactate Dehydrogenase (LDH) release assay. Supernatants of keratinocyte cultures, treated for 72 hours with increasing venom concentrations, were centrifuged at 405&#x000d7; <italic>g</italic> for 10 min, and tested for the presence of LDH, using the CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit, according to the manufacturer's instructions.</p></sec></sec><sec id="sec019"><title>The impact of venom on hemostatic parameters</title><p>Blood samples from healthy donors were placed into tubes containing sodium citrate (3.2%) and centrifuged at 260&#x000d7; <italic>g</italic> at room temperature to obtain platelet-poor plasma (PPP). The PPP samples were aliquoted and stored at -20&#x000b0;C until their use.</p><sec id="sec020"><title>Activated Partial Thromboplastin Time (APTT)</title><p>PPP samples (50 &#x003bc;L) were treated with saline or increasing concentrations of venom and incubated for 3 minutes at 37&#x000b0;C with 50 &#x003bc;L of Cephalin. PPP was then recalcified with CaCl<sub>2</sub> (0.025 M), and the coagulation time was measured over 240 seconds in a Stago Start System (Asni&#x000e8;res-sur-Seine, France). The results are expressed in seconds and <italic>R-time</italic>, which was obtained from the experimental sample/control sample. Disorders in coagulation time were considered significant when the <italic>R-time</italic> was over 1.3 [<xref rid="pntd.0007017.ref054" ref-type="bibr">54</xref>].</p></sec><sec id="sec021"><title>Prothrombin Time (PT)</title><p>PPP samples (50 &#x003bc;L) were treated with saline or increasing concentrations of venom and incubated for 1 minute at 37&#x000b0;C. PPP was then incubated with CaCl<sub>2</sub> (0.025 M) that contained thromboplastin (100 &#x003bc;L), and the coagulation time was followed for 60 seconds using the Stago Start System (Asni&#x000e8;res-sur-Seine, France). The results are expressed in seconds and <italic>R-time</italic>, which was obtained from the experimental sample/control sample. Abnormalities in coagulation time were considered significant when the <italic>R-time</italic> was over 1.3 [<xref rid="pntd.0007017.ref054" ref-type="bibr">54</xref>].</p></sec></sec><sec id="sec022"><title><italic>In vivo</italic> assays</title><sec id="sec023"><title>Lethal Activity of the venom (LD<sub>50</sub>)</title><p>Balb/c mice groups (n = 6) were intraperitoneally (i.p) inoculated with increasing concentrations of venom (20, 40, 60, 80, 100 and 120 &#x003bc;g) [<xref rid="pntd.0007017.ref055" ref-type="bibr">55</xref>] or sterile saline. After inoculation, animals were monitored for 72 hours and LD<sub>50</sub> was calculated using the Probit transformation [<xref rid="pntd.0007017.ref056" ref-type="bibr">56</xref>]. The results are expressed as &#x003bc;g of venom <italic>per</italic> mouse.</p></sec><sec id="sec024"><title>Local reactions: Edematogenic activity and pharmacological modulation</title><p>The venom edematogenic activity was assessed via the method previously published by Yamakawa et al. [<xref rid="pntd.0007017.ref057" ref-type="bibr">57</xref>] with some modifications. Balb/c mice (n = 6) were inoculated with 10 &#x003bc;g of <italic>N</italic>. <italic>annulifera</italic> venom at a volume of 50 &#x003bc;L (sterile saline) in the subcutaneous (s.c) tissue of the plantar region of the animal&#x02019;s left hindpaw. The contralateral hindpaw (control) was inoculated with 50 &#x003bc;L of sterile saline. To assess edematogenic activity, the thickness of the hindpaw was evaluated with a caliper rule (Mitutoyo, Suzano-SP, Brazil; sensibility of 0.01 mm) at different time points before (T0) and over the 24 h, following either venom or saline inoculation (Te). Increases in paw volume are expressed in percentage form (%), calculated with the following formula: (Te-T0)/T0*100.</p><p>To evaluate the contribution of mast cells and different lipid mediators to the hindpaw edema induced by <italic>N</italic>. <italic>annulifera</italic> venom, mice (n = 6 <italic>per</italic> drug) were pretreated with different anti-inflammatory compounds: a) Sodium Cromoglycate, a mast cell degranulation inhibitor (10 mg/kg), administered i.p. for 3 days before edema induction [<xref rid="pntd.0007017.ref058" ref-type="bibr">58</xref>]; b) dexamethasone, an indirect cPLA<sub>2</sub> inhibitor, was given to mice (2 mg/kg) i.p. 2 h before venom inoculation [<xref rid="pntd.0007017.ref059" ref-type="bibr">59</xref>]; c) the non-selective cyclooxygenase inhibitor Indomethacin, was administered (10 mg/kg) i.p. 30 minutes [<xref rid="pntd.0007017.ref060" ref-type="bibr">60</xref>] before venom; d) MK-886, a 5-lipoxigenase-activating protein inhibitor, was administered (5 mg/kg) i.p. 30 minutes [<xref rid="pntd.0007017.ref061" ref-type="bibr">61</xref>] before edema induction; and e) WEB-2086, a Platelet Activating Factor Receptor antagonist, was administered (5 mg/kg) s.c. 1 hour before venom administration [<xref rid="pntd.0007017.ref062" ref-type="bibr">62</xref>, <xref rid="pntd.0007017.ref063" ref-type="bibr">63</xref>]. Dexamethasone and Cromolyn were diluted in saline, while Indomethacin, MK-886, WEB-2086 were diluted in DMSO. Following these pretreatments, edema was induced and monitored for 24 h.</p></sec><sec id="sec025"><title>Systemic reactions</title><p>To analyze the possible systemic reactions induced by <italic>N</italic>. <italic>annulifera</italic> venom, two experimental groups were established. The first measured systemic alterations over time. LD<sub>50</sub> assays were performed to define the sublethal dosing level that was able to induce the deleterious effects of the venom, including an increase in inflammatory parameters, but not kill the animals. LD<sub>50</sub> values that varied between 50 and 75% were tested, and the selected dose for the inflammatory assays was 60% of LD<sub>50</sub>. Balb/c mice (n = 6) were then inoculated with 60% of LD<sub>50</sub> or sterile saline i.p. and euthanized at different time points to obtain blood and collect the organs.</p><p>In another experimental set, it was assessed whether death promoted by venom was preceded by systemic reactions. Animal groups (n = 6) were inoculated with saline or 2 LD<sub>50</sub> of <italic>N</italic>. <italic>annulifera</italic> venom i.p. Immediately after animals&#x02019; death, their blood and organs were collected. Blood samples were obtained by cardiac puncture and were immediately incubated with EDTA (2.5 mg/mL). Aliquots of these samples were used to measure systemic leukocyte changes, while other blood samples were centrifuged at 2800&#x000d7; <italic>g</italic> at 4&#x000b0;C for 10 minutes to isolate plasma. Plasma samples were stored at -80&#x000b0;C and used to measure inflammatory mediators.</p></sec><sec id="sec026"><title>Leukocyte alterations</title><p>To analyze changes in the total number of leukocytes, blood samples were diluted 1:10 in Turk&#x02019;s solution (0.1% crystal violet dye in 2% acetic acid), and the cells were counted in a Neubauer chamber. Blood samples were also submitted for blood smear and stained with a Fast Panoptic stain kit. Differential cell counts were performed by analyzing 100 cells that were identified as lymphocytes, neutrophils or monocytes based on morphologic criteria.</p></sec><sec id="sec027"><title>Detection of inflammatory mediators</title><p>IL-6, TNF-&#x003b1;, MCP-1, IL-12, IFN-&#x003b3; and IL-10 detection was performed using the BD Cytometric Bead Array (CBA) Mouse Inflammation Kit (BD Bioscience). IL-1&#x003b2; and IL-17 quantification was performed using the Mouse IL-1&#x003b2; ELISA (BD Bioscience) and Mouse IL-17 Duo3.2.43 ELISA (R&#x00026;D Systems) kits, respectively. All assays were performed according to the manufacturer&#x02019;s instructions. The results are expressed as pg/mL.</p></sec><sec id="sec028"><title>Histopathologic analysis</title><p>To analyze systemic histopathologic changes, Balb/c mice (n = 6) were inoculated i.p. with a sublethal dose or 2DL<sub>50</sub> of <italic>N</italic>. <italic>annulifera</italic> venom. After euthanasia or death, animals were exsanguinated, and their brains, lungs, hearts, kidneys, spleens and livers were collected. To analyze local histopathological changes, Balb/c mice (n = 3) were injected subcutaneously with 10 &#x003bc;g of <italic>N</italic>. <italic>annulifera</italic> venom at a volume of 50 &#x003bc;L (sterile saline) in the plantar region of their left hindpaws. The contralateral hindpaws (control) were inoculated with 50 &#x003bc;L of sterile saline. Animals were euthanized at different time points (0, 20, 60, 240 and 1440 minutes) and had their hindpaws removed. The hindpaws and organs were fixed in a 10% formaldehyde solution for 24 hours, submitted for routine histology and stained with hematoxylin and eosin (HE). All samples were analyzed with a light microscope and were examined for the presence of necrosis, edema, inflammatory infiltrates or hemorrhagic foci.</p></sec></sec><sec id="sec029"><title>Experimental antivenom production</title><sec id="sec030"><title>Immunogenicity</title><p>H<sub>III</sub> mice (n = 12) were immunized subcutaneously with 10 &#x003bc;g of <italic>N</italic>. <italic>annulifera</italic> venom diluted 1:25 on Al(OH)<sub>3</sub> to achieve a final volume of 200 &#x003bc;L. These animals received three booster doses (5 &#x003bc;g) at 20-day intervals. Control animals were inoculated with sterile saline. Bleeding was performed 10 days after each venom inoculation. Blood was allowed to clot at room temperature for 15 minutes and was then left at 4&#x000b0; C for 6 hours. After centrifugation at 252&#x000d7; <italic>g</italic> and 4&#x000b0; C, the sera were collected and immediately frozen at -20&#x000b0; C.</p></sec><sec id="sec031"><title>Sera antibody titers</title><p>To evaluate the sera antibody titers of immunized animals, ELISA plates (Costar) were coated with 100 &#x003bc;L of <italic>N</italic>. <italic>annulifera</italic> venom (10 &#x003bc;g/mL) and incubated overnight at 4&#x000b0; C. The plates were then blocked with 5% BSA in PBS for 2 hours at 37&#x000b0; C and incubated with crescent dilutions of non-immune or experimental sera samples for 1 hour at room temperature. After incubation, the plates were washed with PBS-Tween 20 0.05%, and incubated with the IgG-HRPO (1:5000 diluted) secondary antibody in 1% BSA/PBS for 1 hour at 37&#x000b0; C. The plates were then washed, and the reactions were developed with OPD substrate according to the manufacturer&#x02019;s instructions. The optical densities were obtained using spectrophotometry (Multiskan EX, Labsystems, Finland) at &#x003bb;492 nm.</p></sec><sec id="sec032"><title>Recognition of venom components using experimental antivenom</title><p>Samples of <italic>N</italic>. <italic>annulifera</italic> venom (15 &#x003bc;g) were separated using 8&#x02013;16% gradient SDS-PAGE [<xref rid="pntd.0007017.ref043" ref-type="bibr">43</xref>] and blotted on nitrocellulose membranes [<xref rid="pntd.0007017.ref045" ref-type="bibr">45</xref>]. The membranes were blocked for 2 hours with 5% BSA in PBS, washed three times with PBS, incubated with normal or experimental sera pools, and diluted 1:5000 in 0.01% PBS/BSA for 1 hour at room temperature. After incubation, the membranes were washed with PBS-0.05% Tween 20, incubated with IgG-AP secondary antibodies, and diluted 1:5000 in 1% BSA/PBS for 1 hour at room temperature. After incubation, the membranes were washed three times in PBS-0.05% Tween 20. Antigenic reactivity was measured by the addition of NBT and BCIP substrates according to the manufacturer&#x02019;s recommendations.</p></sec><sec id="sec033"><title>Serum neutralization of the venom&#x02019;s lethal activity</title><p>To determine the neutralizing potential of the experimental antivenom, samples of the venom, equivalent to 2LD<sub>50</sub> (188.28 &#x003bc;g), were incubated with saline or crescent dilutions of the experimental serum for 30 minutes at 37&#x000b0; C. These mixtures were then i.p. administered to Balb/c mice (n = 6) (200 &#x003bc;L). Animals were observed for 72 hours and the death/survival ratio recorded. The neutralizing potential was calculated by Probit analysis and the results expressed as potency (mg of venom neutralized by mL of experimental serum) [<xref rid="pntd.0007017.ref056" ref-type="bibr">56</xref>].</p></sec></sec><sec id="sec034"><title>Statistical analysis</title><p>Statistical analysis was performed using one-way ANOVA followed by Tukey&#x02019;s Multiple comparison test, two-way ANOVA followed by a Bonferroni multiple comparison or <italic>t-</italic>tests. All statistical analyses were performed using Graphpad Prism 5 software (La Jolla, California, USA). Differences were considered significant when p &#x02264; 0.05.</p></sec></sec><sec sec-type="results" id="sec035"><title>Results</title><sec id="sec036"><title><italic>N</italic>. <italic>annulifera</italic> venom composition</title><p>The analysis of the electrophoretic profile of <italic>N</italic>. <italic>annulifera</italic> venom using a 8&#x02013;16% SDS-polyacrylamide gel, under non-reducing conditions, revealed protein bands with relative molecular masses between ~10 kDa and ~190 kDa. Under reducing conditions, the venom displayed a more simple profile, with main protein bands ranging from ~6 kDa to ~100 kDa (<xref ref-type="fig" rid="pntd.0007017.g001">Fig 1A</xref>), indicating that the venom contains protein in oligomeric state. To better characterize venom proteins, nitrocellulose membranes to which venom samples had been transferred were incubated with the ConA and WGA lectins, which recognize mannose [<xref rid="pntd.0007017.ref064" ref-type="bibr">64</xref>] and N-acetylglucosamine [<xref rid="pntd.0007017.ref065" ref-type="bibr">65</xref>] residues, respectively. <xref ref-type="fig" rid="pntd.0007017.g001">Fig 1B</xref> shows three protein bands (~70, ~86 and ~103 kDa) that interacted with WGA indicating the presence of N-acetylglucosamine. Moreover, three bands that interacted with ConA (~63, ~81 and ~170 kDa) indicated that these proteins contain mannose residues in their carbohydrate moieties (<xref ref-type="fig" rid="pntd.0007017.g001">Fig 1C</xref>).</p><fig id="pntd.0007017.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.g001</object-id><label>Fig 1</label><caption><title>Characterization of the venom components.</title><p>[A] SDS-polyacrilamide gel electrophoresis of <italic>N</italic>. <italic>annulifera</italic> venom. Venom samples (15 &#x003bc;g) were separated using a 8&#x02013;16% SDS-polyacrylamide gel under non-reducing [NR] or reducing [R] conditions and silver stained. Analysis of the presence of [B] N-acetylglucosamine and [C] Mannan residues in the venom. Samples of <italic>N</italic>. <italic>annulifera</italic> venom (15 &#x003bc;g) were separated via SDS-PAGE and blotted onto a nitrocellulose membrane. The membranes were then incubated with the lectins WGA [B] or ConA [C], and the reactions were revealed with DAB plus H<sub>2</sub>O<sub>2</sub>.</p></caption><graphic xlink:href="pntd.0007017.g001"/></fig><p>The venom proteomic analysis using in-solution trypsin digestion and LC-MS/MS resulted in the identification of 79 proteins, including 24 types of venom components with or without enzymatic function, and six proteins of unknown function. Despite the variety of proteins identified in the venom, it is dominated by the presence of 3FTx (27 proteins) (<xref rid="pntd.0007017.t001" ref-type="table">Table 1</xref>; <xref ref-type="supplementary-material" rid="pntd.0007017.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pntd.0007017.s002">S2</xref> Tables; <xref ref-type="supplementary-material" rid="pntd.0007017.s003">S1 Spectra</xref>). Other protein classes identified in the venom include cysteine-rich secretory protein (CRISP), Kunitz-type protease inhibitor, snake venom metalloproteinase (SVMP), snake venom serine proteinase (SVSP), phospholipase A2 (PLA<sub>2</sub>), hyaluronidase (glycosyl hydrolase 56 family) and Cobra Venom Factor (venom complement C3 homolog).</p><table-wrap id="pntd.0007017.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.t001</object-id><label>Table 1</label><caption><title>List of proteins identified in <italic>Naja annulifera</italic> venom by in-solution trypsin digestion and LC-MS/MS analysis<xref ref-type="table-fn" rid="t001fn001">*</xref>.</title></caption><alternatives><graphic id="pntd.0007017.t001g" xlink:href="pntd.0007017.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Protein family</th><th align="left" rowspan="1" colspan="1">Protein ID<xref ref-type="table-fn" rid="t001fn002">**</xref></th><th align="left" rowspan="1" colspan="1">Protein</th><th align="left" rowspan="1" colspan="1"># Peptides</th></tr></thead><tbody><tr><td align="left" rowspan="27" colspan="1">Snake three-finger toxin family</td><td align="left" rowspan="1" colspan="1">P01454</td><td align="left" rowspan="1" colspan="1">Cytotoxin 9</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">P62394</td><td align="left" rowspan="1" colspan="1">Cytotoxin 11</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">P01421</td><td align="left" rowspan="1" colspan="1">Short neurotoxin 4</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">P68419</td><td align="left" rowspan="1" colspan="1">Short neurotoxin 1</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">P01456</td><td align="left" rowspan="1" colspan="1">Cytotoxin 1</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">Q9W717</td><td align="left" rowspan="1" colspan="1">Neurotoxin-like protein NTL2</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">P01463</td><td align="left" rowspan="1" colspan="1">Cytotoxin 2</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">P01453</td><td align="left" rowspan="1" colspan="1">Cytotoxin 10</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">P29181</td><td align="left" rowspan="1" colspan="1">Weak neurotoxin 7</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">P01401</td><td align="left" rowspan="1" colspan="1">Weak toxin CM-11</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">P01399</td><td align="left" rowspan="1" colspan="1">Weak toxin CM-13b</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">P01462</td><td align="left" rowspan="1" colspan="1">Cytotoxin 2</td><td align="left" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">P81782</td><td align="left" rowspan="1" colspan="1">Bucandin</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">P01400</td><td align="left" rowspan="1" colspan="1">Weak toxin S4C11</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">P25674</td><td align="left" rowspan="1" colspan="1">Long neurotoxin 1</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">P25678</td><td align="left" rowspan="1" colspan="1">Weak toxin CM-2a</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">P01457</td><td align="left" rowspan="1" colspan="1">Cytotoxin 5</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Q9W6W6</td><td align="left" rowspan="1" colspan="1">Cytotoxin 10</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">P01422</td><td align="left" rowspan="1" colspan="1">Short neurotoxin 2</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">P82462</td><td align="left" rowspan="1" colspan="1">Muscarinic toxin-like protein 1</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">R4FK68</td><td align="left" rowspan="1" colspan="1">3FTx-Pse-105</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">P01461</td><td align="left" rowspan="1" colspan="1">Cytotoxin 4</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">R4G7H8</td><td align="left" rowspan="1" colspan="1">3FTx-Fur-10</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">P01464</td><td align="left" rowspan="1" colspan="1">Cytotoxin 5</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">P01388</td><td align="left" rowspan="1" colspan="1">Long neurotoxin 2</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">P01389</td><td align="left" rowspan="1" colspan="1">Long neurotoxin 1</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">P01426</td><td align="left" rowspan="1" colspan="1">Short neurotoxin 1</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="8" colspan="1">CRISP family</td><td align="left" rowspan="1" colspan="1">Q7T1K6</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein natrin-1</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">P84808</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein kaouthin-2</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">P0DL15</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein annuliferin-b (Fragment)</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">P84807</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein 25-A (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Q8JI38</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein latisemin</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">F2Q6F2</td><td align="left" rowspan="1" colspan="1">Cysteine-rich seceretory protein Dr-CRPK</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">C1JZW4</td><td align="left" rowspan="1" colspan="1">Opharin</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Q7ZT98</td><td align="left" rowspan="1" colspan="1">Cysteine-rich venom protein ophanin</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="5" colspan="1">Phospholipase A2 family</td><td align="left" rowspan="1" colspan="1">B2BRS4</td><td align="left" rowspan="1" colspan="1">Truncated putative phospholipase A2</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">P25498</td><td align="left" rowspan="1" colspan="1">Acidic phospholipase A2 E</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Q92085</td><td align="left" rowspan="1" colspan="1">Neutral phospholipase A2 B</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">P00605</td><td align="left" rowspan="1" colspan="1">Phospholipase A2 basic</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">P00600</td><td align="left" rowspan="1" colspan="1">Acidic phospholipase A2 DE-II</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="5" colspan="1">SVMP family</td><td align="left" rowspan="1" colspan="1">D6PXE8</td><td align="left" rowspan="1" colspan="1">Zinc metalloproteinase-disintegrin-like atrase-B</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">D5LMJ3</td><td align="left" rowspan="1" colspan="1">Zinc metalloproteinase-disintegrin-like atrase-A</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Q10749</td><td align="left" rowspan="1" colspan="1">Snake venom metalloproteinase-disintegrin-like mocarhagin</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">P82942</td><td align="left" rowspan="1" colspan="1">Hemorrhagic metalloproteinase-disintegrin-like kaouthiagin</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">D3TTC2</td><td align="left" rowspan="1" colspan="1">Zinc metalloproteinase-disintegrin-like atragin</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="4" colspan="1">Type-B carboxylesterase/lipase family</td><td align="left" rowspan="1" colspan="1">A0A098LYB5</td><td align="left" rowspan="1" colspan="1">Carboxylic ester hydrolase</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">R4FKE6</td><td align="left" rowspan="1" colspan="1">Carboxylic ester hydrolase (Fragment)</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Q92035</td><td align="left" rowspan="1" colspan="1">Acetylcholinesterase</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A098LY86</td><td align="left" rowspan="1" colspan="1">Carboxylic ester hydrolase (Fragment)</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="2" colspan="1">Phosphodiesterase family</td><td align="left" rowspan="1" colspan="1">A0A2D0TC04</td><td align="left" rowspan="1" colspan="1">Snake venom phosphodiesterase (PDE)</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A0F7YYZ8</td><td align="left" rowspan="1" colspan="1">Phosphodiesterase</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="2" colspan="1">Lectin family</td><td align="left" rowspan="1" colspan="1">U3FVL3</td><td align="left" rowspan="1" colspan="1">Vesicular integral-membrane protein VIP36</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">R4G314</td><td align="left" rowspan="1" colspan="1">LP-Pse-6</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">Flavin monoamine oxidase family</td><td align="left" rowspan="1" colspan="1">A0A2R4N4Q6</td><td align="left" rowspan="1" colspan="1">Amine oxidase (Fragment)</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">R4FID0</td><td align="left" rowspan="1" colspan="1">Amine oxidase</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="2" colspan="1">NGF family</td><td align="left" rowspan="1" colspan="1">P61899</td><td align="left" rowspan="1" colspan="1">Venom nerve growth factor</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">Q5YF89</td><td align="left" rowspan="1" colspan="1">Venom nerve growth factor 2</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="2" colspan="1">Ohanin/vesprin family</td><td align="left" rowspan="1" colspan="1">P82885</td><td align="left" rowspan="1" colspan="1">Thaicobrin</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A182C6D0</td><td align="left" rowspan="1" colspan="1">Ohanin</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">5'-nucleotidase family</td><td align="left" rowspan="1" colspan="1">U3FYP9</td><td align="left" rowspan="1" colspan="1">Ecto-5-nucleotidase 1c</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">Ankyrin repeat</td><td align="left" rowspan="1" colspan="1">V8NWT6</td><td align="left" rowspan="1" colspan="1">Ankyrin repeat domain-containing protein 34B (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrate/starch-binding module (family 21)</td><td align="left" rowspan="1" colspan="1">V8N6R7</td><td align="left" rowspan="1" colspan="1">Protein phosphatase 1 regulatory subunit 3A (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">DEATH domain, DD</td><td align="left" rowspan="1" colspan="1">V8P0T5</td><td align="left" rowspan="1" colspan="1">Tumor necrosis factor receptor superfamily member 11B</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Endonuclease family</td><td align="left" rowspan="1" colspan="1">V8N4Y2</td><td align="left" rowspan="1" colspan="1">Endonuclease domain-containing 1 protein</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Glutathione peroxidase family</td><td align="left" rowspan="1" colspan="1">V8P395</td><td align="left" rowspan="1" colspan="1">Glutathione peroxidase (Fragment)</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Glycosyl hydrolase 56 family (hyaluronidase)</td><td align="left" rowspan="1" colspan="1">U3FYQ4</td><td align="left" rowspan="1" colspan="1">Hyaluronidase</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">LDH/MDH superfamily</td><td align="left" rowspan="1" colspan="1">V8P6K5</td><td align="left" rowspan="1" colspan="1">L-lactate dehydrogenase</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyruvate kinase family</td><td align="left" rowspan="1" colspan="1">V8P2C8</td><td align="left" rowspan="1" colspan="1">Pyruvate kinase</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">SVSP family</td><td align="left" rowspan="1" colspan="1">A8QL57</td><td align="left" rowspan="1" colspan="1">Snake venom serine protease BmSP (Fragment)</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Thiolase family</td><td align="left" rowspan="1" colspan="1">V8NMW3</td><td align="left" rowspan="1" colspan="1">Non-specific lipid-transfer protein</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Tudor domain</td><td align="left" rowspan="1" colspan="1">V8NEV9</td><td align="left" rowspan="1" colspan="1">Tudor domain-containing protein 6 (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Venom complement C3 homolog family</td><td align="left" rowspan="1" colspan="1">Q91132</td><td align="left" rowspan="1" colspan="1">Cobra venom factor</td><td align="left" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">Venom Kunitz-type family</td><td align="left" rowspan="1" colspan="1">P00986</td><td align="left" rowspan="1" colspan="1">Kunitz-type serine protease inhibitor 2</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="6" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">A0A2D4GN98</td><td align="left" rowspan="1" colspan="1">Uncharacterized protein (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">V8NUN2</td><td align="left" rowspan="1" colspan="1">Transmembrane protein 14C</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A2D4JG71</td><td align="left" rowspan="1" colspan="1">Uncharacterized protein (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A2D4KYJ8</td><td align="left" rowspan="1" colspan="1">Uncharacterized protein (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A2D4H759</td><td align="left" rowspan="1" colspan="1">Uncharacterized protein (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">A0A2D4IS21</td><td align="left" rowspan="1" colspan="1">Uncharacterized protein (Fragment)</td><td align="left" rowspan="1" colspan="1">1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>*Only proteins identified in at least two experimental replicates, with at least 1 unique peptide and posterior error probability &#x02264; 0.01 are listed.</p></fn><fn id="t001fn002"><p>**The first protein entry was selected as a representative of each Protein Group as identified using the MaxQuant software package.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec037"><title>Toxic-Enzymatic properties of <italic>N</italic>. <italic>annulifera</italic> venom</title><p><italic>N</italic>. <italic>annulifera</italic> venom showed no proteolytic activity on zymography using gelatin as substrate. Under the same experimental conditions, proteins from the positive control of <italic>B</italic>. <italic>jararaca</italic> venom showed gelatinolytic activity, as demonstrated by clear regions in the gel (bands with molecular mass above 60 kDa) (<xref ref-type="fig" rid="pntd.0007017.g002">Fig 2A</xref>). However, when proteolytic activity on fibrinogen was assessed, it was observed that the venom contained proteinases that were able to cleave this protein at the alpha chain, generating a fragment with a molecular mass of ~ 40 kDa (<xref ref-type="fig" rid="pntd.0007017.g002">Fig 2B</xref>). In addition, when inhibitors were added to the reactions, cleavage was inhibited by 1, 10 Phe and PMSF, demonstrating the contributions of SVMP and SVSP to this hydrolysis (<xref ref-type="fig" rid="pntd.0007017.g002">Fig 2B</xref>).</p><fig id="pntd.0007017.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.g002</object-id><label>Fig 2</label><caption><title>Toxic-enzyme properties of <italic>N</italic>. <italic>annulifera</italic> venom.</title><p>[A] Zymography: Samples of <italic>N</italic>. <italic>annulifera</italic> venom (30 &#x003bc;g) were assessed via 10% SDS-PAGE in the presence of 1 mg/mL gelatin and then incubated with the substrate buffer. Gels were stained with <italic>Comassie Brilliant Blue</italic>. The venom of <italic>B</italic>. <italic>jararaca</italic> (10 &#x003bc;g) was used as a positive control. [B] Fb cleavage: Fb samples (30 &#x003bc;g) were incubated with <italic>N</italic>. <italic>annulifera</italic> venom (5 &#x003bc;g) with or without metallo- (10 mM) and serine proteinase (10 mM) inhibitors for 1 hour. Samples were then analyzed via SDS-PAGE (8&#x02013;16% gradient gel) and stained with <italic>Comassie Brilliant Blue</italic>. [C] Hyaluronidase activity: samples of <italic>N</italic>. <italic>annulifera</italic> venom (20 &#x003bc;g) were incubated at 37&#x000b0;C for 15 minutes in a solution containing hyaluronic acid. After the incubation, the reactions were stopped with CTAB and the absorbances were measured at &#x003bb; 405 nm with a spectrophotometer. As a positive control, <italic>T</italic>. <italic>serrulatus</italic> (20 &#x003bc;g) scorpion venom was used. The results are representative of three separate experiments and expressed as UTR/mg of venom &#x000b1; SD. Statistical analysis was performed using the <italic>t-test</italic> (*** <italic>p&#x02264;</italic> 0.05). [D] PLA<sub>2</sub> activity: Samples of <italic>N</italic>. <italic>annulifera</italic> venom (0.5 &#x003bc;g) were incubated at 37&#x000b0;C with a phospholipid mix that contained 10 mM phosphatidylcholine and 10 mM phosphatidylglycerol. Increased fluorescence was measured for 10 minutes. As a positive control, <italic>C</italic>. <italic>d</italic>. <italic>terrificus</italic> venom (0.5 &#x003bc;g) was used. The results are representative of three separate experiments and expressed as specific activity (UF <italic>per</italic> &#x003bc;g of venom <italic>per</italic> minute) &#x000b1; SD. Statistical analysis was performed using <italic>t-test</italic> (*** <italic>p&#x02264;</italic> 0.05). [E] Cytotoxic activity: The HaCat human keratinocyte cell lineage was cultured in DMEM medium and incubated during 72 hours with increasing amounts of <italic>N</italic>. <italic>annulifera</italic> venom. The effect on cell viability was evaluated using the MTT method and by measuring LDH release from human keratinocytes exposed to the venom, using the CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit. Statistical analysis was performed using One Way ANOVA (*** <italic>p&#x02264;</italic> 0.05) &#x000b1; SD.</p></caption><graphic xlink:href="pntd.0007017.g002"/></fig><p>The hyaluronidase activity of <italic>N</italic>. <italic>annulifera</italic> snake venom was assessed via a turbidimetric assay, and the results are expressed in UTR. It was demonstrated that <italic>N</italic>. <italic>annulifera</italic> venom has a low hyaluronidase activity (UTR = 14.4) compared to the positive control <italic>T</italic>. <italic>serrulatus</italic> scorpion venom (UTR = 52.8) (<xref ref-type="fig" rid="pntd.0007017.g002">Fig 2C</xref>).</p><p>PLA<sub>2</sub> activity was measured with a fluorimetric assay, and the results obtained are expressed as specific activity (SA: UF/min/&#x003bc;g venom). <xref ref-type="fig" rid="pntd.0007017.g002">Fig 2D</xref> shows that <italic>N</italic>. <italic>annulifera</italic> snake venom has significantly lower phospholipase activity (SA: 566.2) than the <italic>C</italic>. <italic>d</italic>. <italic>terrificus</italic> venom positive controls (SA: 3061.3).</p><p>Cytotoxic properties of the venom were evaluated by cell viability and LHD release assays. <italic>N</italic>. <italic>annulifera</italic> venom was able to reduce human keratinocyte viability in a dose-dependent manner but was not able to promote LDH release by the cells (<xref ref-type="fig" rid="pntd.0007017.g002">Fig 2E</xref>).</p></sec><sec id="sec038"><title>The impact of <italic>N</italic>. <italic>annulifera</italic> on hemostasis</title><p><italic>N</italic>. <italic>annulifera</italic> venom induced disturbances in the Activated Partial Thromboplastin Time in a dose dependent manner (<xref rid="pntd.0007017.t002" ref-type="table">Table 2</xref>). Platelet-poor plasma (PPP) samples were incoagulable when the highest venom concentrations were used (12.5 to 50 &#x003bc;g), while the coagulation time (seconds) was significantly prolonged at lower concentrations (2.5 to 6.25 &#x003bc;g) (<italic>p&#x02264;</italic> 0.05). Moreover, the <italic>R-time</italic> shows that the disturbances promoted by <italic>N</italic>. <italic>annulifera</italic> venom were severe, as they were much higher than normal. Prothrombin Time assays demonstrated that the venom led to a significant prolongation in the coagulation time of PPP at the highest venom concentrations, <italic>i</italic>.<italic>e</italic>., 25 and 50 &#x003bc;g. Besides that, both venom concentrations were able to cause a significant alteration in the <italic>R-time</italic> (<xref rid="pntd.0007017.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pntd.0007017.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.t002</object-id><label>Table 2</label><caption><title>Alterations in aTTP and PT induced by <italic>N</italic>. <italic>annulifera</italic> venom.</title></caption><alternatives><graphic id="pntd.0007017.t002g" xlink:href="pntd.0007017.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Assay</th><th align="justify" rowspan="1" colspan="1">C</th><th align="justify" rowspan="1" colspan="1">2.5 &#x003bc;g</th><th align="justify" rowspan="1" colspan="1">3.12 &#x003bc;g</th><th align="justify" rowspan="1" colspan="1">6.25 &#x003bc;g</th><th align="justify" rowspan="1" colspan="1">12.5 &#x003bc;g</th><th align="justify" rowspan="1" colspan="1">25 &#x003bc;g</th><th align="justify" rowspan="1" colspan="1">50 &#x003bc;g</th></tr></thead><tbody><tr><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1"><bold>aTTP</bold></td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">38</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">78.4***</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">92.8***</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">98.9***</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">-***</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">-***</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">-***</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold><italic>R-time</italic></bold></td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">2.1***</td><td align="justify" rowspan="1" colspan="1">2.3***</td><td align="justify" rowspan="1" colspan="1">2.3***</td><td align="justify" rowspan="1" colspan="1">6.3***</td><td align="justify" rowspan="1" colspan="1">6.3***</td><td align="justify" rowspan="1" colspan="1">6.3***</td></tr><tr><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1"><bold>PT</bold></td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">15.5</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">15.5</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">15.5</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">15.5</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">15.3</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">18.3**</td><td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">33.6***</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold><italic>R-time</italic></bold></td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1.33**</td><td align="justify" rowspan="1" colspan="1">2.2***</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>aTTP: Activated Partial Thromboplastin Time; PT: Prothrombin Time; -: Incoagulable; C: Control (PPP samples treated with sterile saline); <italic>R-time</italic>: scale of abnormalities in coagulation time. Statistical analysis was performed using Two Way ANOVA (** and *** <italic>p&#x02264;</italic> 0.05) &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec039"><title>Toxicity of <italic>N</italic>. <italic>annulifera</italic> venom in the murine model</title><sec id="sec040"><title>Local reactions</title><p>To evaluate the edematogenic activity of <italic>N</italic>. <italic>annulifera</italic> venom, Balb/c mice were inoculated with 10 &#x003bc;g of venom into their left hind footpads, and their paws were measured at different time points. The venom was able to induce a significant rapid onset of edema, with its maximum peak (110.13% of increase on paw volume) reached 20 minutes after inoculation. It returned to basal level 24 hours after venom inoculation (<xref ref-type="fig" rid="pntd.0007017.g003">Fig 3A</xref>).</p><fig id="pntd.0007017.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.g003</object-id><label>Fig 3</label><caption><title>Local alterations induced by <italic>N</italic>. <italic>annulifera</italic> venom.</title><p>[A] Edema: samples of venom (10 &#x003bc;g/50 &#x003bc;L) or sterile saline were injected into the left or right hind footpad, respectively, of Balb/c mice (n = 6). Paw edema was assessed by measuring the paw thickness using a caliper rule before (T0) and after inoculation with venom or saline (Te). The increased paw volume was expressed as percentage (%) and was calculated with the following formula: (Te-T0)/T0*100. Statistical analysis was performed using two-way ANOVA, followed by the Bonferroni multiple comparison test (***<italic>p&#x02264;</italic> 0.05) &#x000b1; SD. [B] The effect of inhibitors on the paw edema induced by <italic>N</italic>. <italic>annulifera</italic> venom: groups of Balb/c mice (n = 6) were treated with different inhibitors before induction of edema with venom: Cromolyn, a mast cell degranulation inhibitor (10 mg/kg, three days consecutively before the edema, i.p. route); dexamethasone (Dexa), a cPLA<sub>2</sub> inhibitor (2 mg/kg, 2 hours before the edema, i.p. route); indomethacin (Indo), a COX isoform inhibitor (10 mg/kg, 30 minutes before the edema, i.p. route); MK886, a 5-lipoxygenase-activating protein inhibitor (5 mg/kg, 30 minutes before the edema, i.p. route); and WEB2086, a PAFR antagonist (5 mg/kg, 1 hour before the edema, s.c. route). After treatment, edema was induced, and the paws were measured with a caliper rule at several time points. The increased paw volume was expressed as a percentage. Statistical analysis was performed using two-way ANOVA, followed by the Bonferroni multiple comparison test (***<italic>p&#x02264;</italic> 0.05) &#x000b1; SD. [C] Histopathological changes promoted by <italic>N</italic>. <italic>annulifera</italic> venom: samples of <italic>N</italic>. <italic>annulifera</italic> venom (10 &#x003bc;g/50 &#x003bc;L) were injected into the left hind paw of Balb/c mice (n = 6). The contralateral paws were injected with sterile saline (50 &#x003bc;L) to serve as controls. The animals were euthanized at different time points, and their paws were removed and submitted for histopathological analysis. Control group [Panel 1]: epidermis (Ep), dermis (De), sweat glands (Sg) and muscle tissue (Mt). Experimental group [Panel 2]: arrows highlight vascular congestion and a perivascular inflammatory infiltrate; asterisks indicate areas of edema. The rectangle indicates areas of neutrophil infiltration [Panel 3] and myonecrosis [Panels 4, 5]. The arrow and asterisk in Panel 5 indicate dead and living cells, respectively. Scale = 10&#x003bc;m.</p></caption><graphic xlink:href="pntd.0007017.g003"/></fig><p>In addition to the evaluation of edematogenic activity, the contribution of mast cell and lipid mediators to edema development was also assessed. It was found that mast cell degranulation is important for the earliest development (10&#x02013;30 minutes) of edema as treatment with Cromolyn, a mast cell degranulation inhibitor, was able to reduce swelling (<xref ref-type="supplementary-material" rid="pntd.0007017.s004">S1A Fig</xref>). Dexamethasone, a synthetic corticosteroid compound with a potent anti-inflammatory activity, had a strong effect on the paw edema induced by <italic>N</italic>. <italic>annulifera</italic> venom. It was able to decrease hindpaw thickness throughout the duration of edema, mainly during the early stages (10&#x02013;30 minutes), suggesting that lipid mediators participate in the development of edema (<xref ref-type="supplementary-material" rid="pntd.0007017.s004">S1B Fig</xref>). Indomethacin, a non-selective COX inhibitor, was also able to reduce the degree of edema (10 to 120 minutes), suggesting that prostaglandins and thromboxanes may contribute to the local reaction to the venom. However, treatment with Indomethacin was not able to control swelling during the late phase (180 to 1440 minutes) (<xref ref-type="supplementary-material" rid="pntd.0007017.s004">S1C Fig</xref>). A similar effect was observed in animals treated with a FLAP inhibitor (<xref ref-type="supplementary-material" rid="pntd.0007017.s004">S1D Fig</xref>). The PAFR blocker WEB-2086 demonstrated inhibitory action only in the earliest phases of the edema (20&#x02013;30 minutes) (<xref ref-type="supplementary-material" rid="pntd.0007017.s004">S1E Fig</xref>). Although all inhibitors showed different modulation profiles, they were able to significantly decrease the edema at its peak [<xref ref-type="fig" rid="pntd.0007017.g003">Fig 3B</xref>].</p><p>Histopathologic analyses showed that the venom promotes several changes, ranging from mild to intense, at all time periods [<xref ref-type="fig" rid="pntd.0007017.g003">Fig 3C</xref>]. After inoculation with the venom, it was observed that it promotes an acute inflammatory response at the inoculation site, with a disorganized dermal collagen matrix, subcutaneous edema, vascular congestion [Panel 2], mild erythrocyte extravasation and neutrophil migration to the dermis and muscle [Panels 3, 4, 5]. Myonecrosis was also observed [Panels 4, 5] along with polymorphonuclear cell infiltration. These alterations persisted for several hours. However, after 24 hours of inoculation, a decrease in the subcutaneous edema was observed, along with the absence of vascular congestion and few remaining neutrophils in the tissue. By contrast, an increased number of mononuclear cells and reorganization of the dermal collagen matrix was observed [Panel 6].</p></sec></sec><sec id="sec041"><title>Lethal dose</title><p>LD<sub>50</sub> was determined 72 hours after venom administration. Prior to their death, animals presented with several clinical findings of envenomation, including apathy, bending at the column, a rough hair coat, dyspnea and paralysis of their hind limbs. LD<sub>50</sub> was calculated with a probit analysis with a 95% confidence interval and was found to be 94.14 &#x003bc;g (68.78&#x02013;115.74).</p></sec><sec id="sec042"><title>Systemic reactions induced by <italic>N</italic>. <italic>annulifera</italic> venom</title><p>The systemic reactions promoted by the venom were evaluated using two different experimental protocols. By injecting 60% (56.48 &#x003bc;g) (Sublethal dose) of LD<sub>50</sub> of <italic>N</italic>. <italic>annulifera</italic> venom, it was observed that animals presented several clinical findings of envenomation, including apathy, bending at the column, a rough hair coat, dyspnea and difficulty walking. This dose was also able to cause alterations in some systemic parameters, such as a decrease of circulating lymphocytes [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4A</xref>] and an increased number of circulating neutrophils [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4B</xref>]. Nonetheless, this dose was not able to lead to changes in the total number of leukocytes and histological organs damage. However, a sublethal dose promoted an increase in the plasma levels of MCP-1 [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4C</xref>] and IL-6 [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4D</xref>]. These alterations persisted for several hours. However, 24 hours after experimental envenomation, all of these parameters returned to their normal values.</p><fig id="pntd.0007017.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.g004</object-id><label>Fig 4</label><caption><title>Systemic changes promoted by <italic>N</italic>. <italic>annulifera</italic> venom.</title><p>Balb/c mice were injected with either a [A-D] sublethal (56.48 &#x003bc;g) dose or [E-I] 2LD<sub>50</sub> (188.28 &#x003bc;g) of venom intraperitoneally. After death, animals were exsanguinated and some organs were fixed in a 10% formaldehyde solution and submitted for histologic analysis. [A, B, F] Leukocyte alterations: blood samples obtained from the animals were diluted in Turk&#x02019;s solution or submitted for either a blood smear or Fast Panoptic stain to analyze total and differential leukocyte alterations. [I] Histopathological analysis: tissues were analyzed under a light microscope to detect histological alterations. Lungs: bronchiole (Br), blood vessel (Bv), alveoli (Al). Arrow and asterisk indicate vascular congestion and multifocal hemorrhage, respectively. Scale = 10&#x003bc;m. [C, D, G, H] Increased plasma levels of inflammatory mediators: plasma samples were submitted for CBA (BD Bioscience PharMingen, EUA) or ELISA (BD Bioscience PharMingen, EUA) (R&#x00026;D Systems) according to the manufacturer&#x02019;s instructions. The results are expressed as pg/mL. Statistical analyses were performed using Graphpad Prism by means of a 2-way ANOVA followed by the Bonferroni multiple comparison test (***<italic>p&#x02264;</italic> 0.05) &#x000b1; SD.</p></caption><graphic xlink:href="pntd.0007017.g004"/></fig><p>Injection of 2LD<sub>50</sub> led to several clinical findings of envenomation, such as apathy, bending at the column, a rough hair coat, dyspnea, hind limb paralysis and death. In addition to these clinical findings, histopathologic alterations were observed in the lungs, among these, moderate vascular congestion and multiple hemorrhagic foci [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4I</xref>]. Furthermore, the animals demonstrated leukocytosis [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4E</xref>] characterized by neutrophilia and monocytosis [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4F</xref>], as well as increased plasma levels of MCP-1 [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4G</xref>] and IL-6 [<xref ref-type="fig" rid="pntd.0007017.g004">Fig 4H</xref>].</p></sec><sec id="sec043"><title><italic>N</italic>. <italic>annulifera</italic> venom immunogenicity and antivenom production</title><p>The immunogenicity of <italic>N</italic>. <italic>annulifera</italic> snake venom was evaluated in H<sub>III</sub> mice immunized with 10 &#x003bc;g of venom. The antibody titers were determined by ELISA. <xref ref-type="fig" rid="pntd.0007017.g005">Fig 5A</xref> presents the antibody response over time. <italic>N</italic>. <italic>annulifera</italic> venom is highly immunogenic, promoting the production of high antibody titers, already after the second immunization dose. The recognition profile of the venom proteins by the experimental <italic>N</italic>. <italic>annulifera</italic> mouse antiserum was determined by Western Blot. <xref ref-type="fig" rid="pntd.0007017.g005">Fig 5B</xref> shows that the experimental serum was able to recognize venom components, mainly proteins with Mr above 50 kDa. Moreover, as determined by Probit analysis, it was shown that this antivenom was able to neutralize the <italic>N</italic>. <italic>annulifera</italic> venom lethal activity with a high potency, <italic>i</italic>.<italic>e</italic>., 1 ml of antivenom was able to neutralize 4.5 mg of venom.</p><fig id="pntd.0007017.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007017.g005</object-id><label>Fig 5</label><caption><title><italic>N</italic>. <italic>annulifera</italic> venom immunogenicity, antivenom production and serum neutralization.</title><p>[A] Antibody titers: ELISA plates were coated with 10 &#x003bc;g/mL venom (100 &#x003bc;L/well), incubated with increasing dilutions of non-immune (NI) or experimental sera obtained from H<sub>III</sub> mice, and incubated with anti-mouse HRPO-conjugated IgG (1:5000). The reaction was performed with the addition of OPD and H<sub>2</sub>O<sub>2</sub>, and spectrophotometric readings were taken at &#x003bb; 492 nm. [B] Western Blot: samples of the venom (15 &#x003bc;g) were separated via 8&#x02013;16% gradient SDS-PAGE, blotted onto nitrocellulose membranes and incubated with the experimental serum diluted to 1:5,000 (&#x003b1; Na). The membranes were incubated with conjugated anti-mouse IgG-AP (1:7,500), and the reactions were started by adding NBT/BCIP.</p></caption><graphic xlink:href="pntd.0007017.g005"/></fig></sec></sec><sec sec-type="conclusions" id="sec044"><title>Discussion</title><p>In this study, we characterized some of the biochemical, toxic, immunogenic and physiopathologic properties of the venom from <italic>N</italic>. <italic>annulifera</italic>, which is a medically important snake related to accidental bites in the countries of Sub-Saharan Africa. The results show that <italic>N</italic>. <italic>annulifera</italic> venom contains several toxic components able to induce systemic inflammation, which may contribute to the pathology observed in envenomed individuals. Moreover, the venom is immunogenic, an important feature that must be considered during the production of a therapeutic anti-<italic>N</italic>. <italic>annulifera</italic> antivenom.</p><p>Electrophoretic analysis <italic>of N</italic>. <italic>annulifera</italic> venom showed that it contains several components, including low molecular mass proteins, which suggested the presence of neurotoxins [<xref rid="pntd.0007017.ref018" ref-type="bibr">18</xref>], among these, 3FTx [<xref rid="pntd.0007017.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0007017.ref015" ref-type="bibr">15</xref>] and PLA<sub>2</sub> [<xref rid="pntd.0007017.ref016" ref-type="bibr">16</xref>]. The presence of these components in the venom was confirmed by trypsin digestion of proteins and LC-MS/MS analysis. These components may be responsible for some of the clinical findings observed during envenomation, such as heart damage and systemic inflammation in dogs [<xref rid="pntd.0007017.ref035" ref-type="bibr">35</xref>], as well as respiratory arrest in humans [<xref rid="pntd.0007017.ref023" ref-type="bibr">23</xref>]. The data from this study corroborate the results of other studies, which showed the presence of these components in <italic>N</italic>. <italic>annulifera</italic> venom [<xref rid="pntd.0007017.ref037" ref-type="bibr">37</xref>, <xref rid="pntd.0007017.ref038" ref-type="bibr">38</xref>, <xref rid="pntd.0007017.ref039" ref-type="bibr">39</xref>, <xref rid="pntd.0007017.ref040" ref-type="bibr">40</xref>, <xref rid="pntd.0007017.ref041" ref-type="bibr">41</xref>, <xref rid="pntd.0007017.ref042" ref-type="bibr">42</xref>]. Envenomed individuals from South Africa showed local dermonecrotic injury after a bite, which could be caused by the high content of cytotoxins, as shown in our LC-MS/MS analysis. In accordance with data from Panagides and colleagues [<xref rid="pntd.0007017.ref066" ref-type="bibr">66</xref>], here we also showed that <italic>N</italic>. <italic>annulifera</italic> venom could promote decrease in human epidermal cells viability, as evaluated by the MTT method. However, it was not possible to detect release of LDH by these cells, which possibly indicate that the keratinocyte membranes were not damaged and that the cell death promoted by <italic>N</italic>. <italic>annulifera</italic> could be due to apoptosis [<xref rid="pntd.0007017.ref067" ref-type="bibr">67</xref>] and not necrosis. Alternatively, it is possible to consider that <italic>N</italic>. <italic>annulifera</italic> venom contains components able to reduce mitochondrial activity, since MTT method evaluates cell viability as enzymatic conversion of the tetrazolium compound to water insoluble formazan crystals by dehydrogenases occurring in the mitochondria of living cells.</p><p>Western Blot lectin analysis demonstrated the presence of mannose and N-acetylglucosamine residues in <italic>N</italic>. <italic>annulifera</italic> venom proteins. These carbohydrate residues were found in the venom proteins of different genera of snakes [<xref rid="pntd.0007017.ref046" ref-type="bibr">46</xref>, <xref rid="pntd.0007017.ref068" ref-type="bibr">68</xref>, <xref rid="pntd.0007017.ref069" ref-type="bibr">69</xref>, <xref rid="pntd.0007017.ref070" ref-type="bibr">70</xref>], including in important toxic components, such as SVSP and SVMP [<xref rid="pntd.0007017.ref069" ref-type="bibr">69</xref>, <xref rid="pntd.0007017.ref070" ref-type="bibr">70</xref>]. Although we have not identified the families of these glycosylated components, it is possible that some of them are linked to SVMPs or SVSPs, as they have predicted molecular masses similar to some of the previously described glycosylated proteolytic enzymes from viperid venoms [<xref rid="pntd.0007017.ref069" ref-type="bibr">69</xref>, <xref rid="pntd.0007017.ref070" ref-type="bibr">70</xref>]. Moreover, SVMPs and SVSPs were detected in <italic>N</italic>. <italic>annulifera</italic> venom by LC-MS/MS. Proteins containing these carbohydrate residues are also present in many pathogens, such as bacteria and fungi, and can be recognized by different immune cells and molecules, triggering inflammatory and immune responses [<xref rid="pntd.0007017.ref071" ref-type="bibr">71</xref>, <xref rid="pntd.0007017.ref072" ref-type="bibr">72</xref>]. This recognition could contribute to the clinical manifestations observed during envenomation, such as the systemic inflammation observed in dogs [<xref rid="pntd.0007017.ref035" ref-type="bibr">35</xref>].</p><p>Functional biochemical assays were performed to confirm the presence of some of the toxic-enzymatic components found in the LC-MS/MS analysis. The presence of proteinases in animal venoms can contribute to different clinical manifestations during envenomation, such as inflammation, tissue damage, disturbances in coagulation and bleeding [<xref rid="pntd.0007017.ref073" ref-type="bibr">73</xref>]. In elapid venoms, proteolytic activity is usually low or nonexistent [<xref rid="pntd.0007017.ref026" ref-type="bibr">26</xref>, <xref rid="pntd.0007017.ref074" ref-type="bibr">74</xref>, <xref rid="pntd.0007017.ref075" ref-type="bibr">75</xref>]. In contrast to the data shown by Phillips et al. [<xref rid="pntd.0007017.ref076" ref-type="bibr">76</xref>], under the experimental conditions used in this paper, <italic>N</italic>. <italic>annulifera</italic> venom did not show any proteolytic activity on either gelatin. However, although detected at low abundance in the proteomic analysis, the venom contains SVMP and SVSP able to cleave the fibrinogen alpha chain, which suggests that these proteinases can contribute to the hemostatic alterations as observed in dogs envenomated by <italic>N</italic>. <italic>annulifera</italic> [<xref rid="pntd.0007017.ref036" ref-type="bibr">36</xref>].</p><p>Hyaluronic acid is cellular cement that, together with other components of the extracellular matrix, forms a protective gel that prevents the entry of foreign agents. A variety of animal venoms contain hyaluronidases, which cleave hyaluronic acid molecules to facilitate access of the venom from the tissue to the bloodstream. This enzyme is also called &#x0201c;spreading factor&#x0201d; [<xref rid="pntd.0007017.ref077" ref-type="bibr">77</xref>], and its action can promote local and systemic inflammation by increasing tissue permeability [<xref rid="pntd.0007017.ref078" ref-type="bibr">78</xref>]. Moreover, the products derived from hyaluronic acid cleavage, which can be recognized by immune receptors, such as TLR2 and 4, trigger the production of inflammatory mediators, such as cytokines and chemokines [<xref rid="pntd.0007017.ref079" ref-type="bibr">79</xref>]. <italic>N</italic>. <italic>annulifera</italic> venom showed evidence of hyaluronidase activity, but it was relatively low compared with other elapid venoms from the <italic>Naja</italic> [<xref rid="pntd.0007017.ref074" ref-type="bibr">74</xref>] and <italic>Micrurus</italic> [<xref rid="pntd.0007017.ref016" ref-type="bibr">16</xref>] genera, and accordingly, only one hyaluronidase was identified by mass spectrometry in the venom.</p><p>PLA<sub>2</sub> belongs to a superfamily of lipolytic enzymes that catalyze specific hydrolysis of the ester linkage at the <italic>sn-2</italic> position of glycerophospholipids, generating arachidonic acid and lysophospholipids. PLA<sub>2</sub>-like proteins found in snake venoms may be devoid of catalytic activity, although it may exhibit myotoxic or neurotoxic activities [<xref rid="pntd.0007017.ref080" ref-type="bibr">80</xref>, <xref rid="pntd.0007017.ref081" ref-type="bibr">81</xref>]. Moreover, these enzymes may present with other toxic properties during envenomation, such as the ability to cause cytotoxicity and inflammation [<xref rid="pntd.0007017.ref082" ref-type="bibr">82</xref>, <xref rid="pntd.0007017.ref083" ref-type="bibr">83</xref>]. As predicted by LC-MS/MS, the presence of PLA<sub>2</sub> activity in <italic>N</italic>. <italic>annulifera</italic> venom was also observed in enzymatic assays. Nonetheless, <italic>N</italic>. <italic>annulifera</italic> venom exhibits a very lower content of PLA2 /enzymatic activity when compared to other <italic>Naja</italic> venoms [<xref rid="pntd.0007017.ref084" ref-type="bibr">84</xref>, <xref rid="pntd.0007017.ref085" ref-type="bibr">85</xref>, <xref rid="pntd.0007017.ref086" ref-type="bibr">86</xref>, <xref rid="pntd.0007017.ref087" ref-type="bibr">87</xref>, <xref rid="pntd.0007017.ref088" ref-type="bibr">88</xref>], suggesting a strong interspecific variation associated to this particular toxin.</p><p>As observed in dogs, we showed here that <italic>N</italic>. <italic>annulifera</italic> venom promoted hemostatic disturbances in human plasma, making it incoagulable. These disturbances in the hemostatic system can be attributed to the fibrinogenolytic proteinases detected in the venom, or to PLA<sub>2</sub> found in the LC-MS/MS analysis, since these components can promote plasma incoagulability via direct binding to FXa, thereby preventing thrombin generation [<xref rid="pntd.0007017.ref089" ref-type="bibr">89</xref>, <xref rid="pntd.0007017.ref090" ref-type="bibr">90</xref>, <xref rid="pntd.0007017.ref091" ref-type="bibr">91</xref>, <xref rid="pntd.0007017.ref092" ref-type="bibr">92</xref>]. This phenomenon, promoted by several species of <italic>Naja</italic> venom, has been observed in different clinical and experimental studies [<xref rid="pntd.0007017.ref093" ref-type="bibr">93</xref>, <xref rid="pntd.0007017.ref094" ref-type="bibr">94</xref>]. It is therefore very important to evaluate the mechanisms involved in these alterations and their consequence, since the current literature on the topic is scarce. In addition, these alterations may be a therapeutic target for <italic>Naja</italic> envenomation.</p><p>In our <italic>in vivo</italic> experimental model, the venom was able to induce swelling and several histopathologic changes in the hind paws of mice, that decreased only after 24 hours. Among these tissue alterations, myonecrosis associated with inflammation was observed, an event that is commonly found in experimental models of Elapidae envenomation, which is attributed to cytotoxins and PLA<sub>2</sub> [<xref rid="pntd.0007017.ref095" ref-type="bibr">95</xref>, <xref rid="pntd.0007017.ref096" ref-type="bibr">96</xref>].</p><p>The inflammatory events promoted by the venom may be attributed to hyaluronidase, PLA<sub>2</sub>, glycosylated proteins, SVSP and SVMP since they can promote different inflammatory events, which include complement activation, mast cell degranulation, release of eicosanoids and cytokines and leukocyte homing [<xref rid="pntd.0007017.ref016" ref-type="bibr">16</xref>, <xref rid="pntd.0007017.ref026" ref-type="bibr">26</xref>, <xref rid="pntd.0007017.ref027" ref-type="bibr">27</xref>, <xref rid="pntd.0007017.ref058" ref-type="bibr">58</xref>, <xref rid="pntd.0007017.ref059" ref-type="bibr">59</xref>, <xref rid="pntd.0007017.ref060" ref-type="bibr">60</xref>, <xref rid="pntd.0007017.ref061" ref-type="bibr">61</xref>, <xref rid="pntd.0007017.ref083" ref-type="bibr">83</xref>]. Knowing that <italic>N</italic>. <italic>annulifera</italic> venom promotes inflammation and pain in humans and dogs [<xref rid="pntd.0007017.ref031" ref-type="bibr">31</xref>, <xref rid="pntd.0007017.ref032" ref-type="bibr">32</xref>, <xref rid="pntd.0007017.ref033" ref-type="bibr">33</xref>, <xref rid="pntd.0007017.ref034" ref-type="bibr">34</xref>, <xref rid="pntd.0007017.ref035" ref-type="bibr">35</xref>, <xref rid="pntd.0007017.ref036" ref-type="bibr">36</xref>], which were also observed in our experimental model, pharmacologic studies were performed to analyze the role of some inflammatory mediators in the edema process. Pre-treating mice with different compounds that were able to modulate different steps of the inflammatory process, including, mast cell degranulation (Cromolyn), lipid mediator production (Dexamethasone, Indomethacin and MK-886) and action (WEB-2086) significantly decreased the edema promoted by <italic>N</italic>. <italic>annulifera</italic> venom. All of the compounds showed a similar pattern of inhibiting peak edema. However, cPLA<sub>2</sub>, COX isoforms and FLAP inhibitors controlled the edema for a long time, suggesting a stronger contribution of eicosanoids, such as prostaglandins, thromboxanes and leukotrienes, to this process. Moreover, it is possible that these lipid mediators may contribute to the pain observed in humans after a bite, making them good therapeutic targets for the local reactions promoted by <italic>N</italic>. <italic>annulifera</italic> venom.</p><p>The LD<sub>50</sub> of <italic>N</italic>. <italic>annulifera</italic>, established here via i.p. route in Balb/c mice, was 94.14 &#x003bc;g. Ramos-Cerrillo and collaborators [<xref rid="pntd.0007017.ref056" ref-type="bibr">56</xref>] showed that the <italic>N</italic>. <italic>annulifera</italic> venom LD<sub>50</sub> when administered intravenously was 53.9 &#x003bc;g. To evaluate whether <italic>N</italic>. <italic>annulifera</italic> venom was able to promote systemic changes, a sublethal dose of the venom was established, and different inflammatory parameters were evaluated. As in dogs envenomed by <italic>N</italic>. <italic>annulifera</italic> [<xref rid="pntd.0007017.ref034" ref-type="bibr">34</xref>], it was observed that a sublethal dose of the venom promotes acute systemic inflammation, which was characterized by neutrophilia and increased levels of IL-6 and MCP-1 in the plasma. However, unlike dogs envenomed by <italic>N</italic>. <italic>annulifera</italic> the sublethal dose was not able to cause organ injury, as observed by Langhorn et al. [<xref rid="pntd.0007017.ref035" ref-type="bibr">35</xref>] in dogs.</p><p>By administering a superdose (2LD<sub>50</sub>) of venom to mice, it was possible to observe systemic inflammation, which was characterized by an increase in the plasma levels of IL-6 and MCP-1. However, in contrast with the sublethal dose, the 2DL<sub>50</sub> dose caused leukocytosis, which was characterized by neutrophilia and monocytosis. In addition, dead animals showed multifocal hemorrhaging in their lungs.</p><p>These data suggest that the systemic inflammatory process induced by high doses of venom may be associated with the lung alterations observed in humans. In fact, in different models of hemorrhagic shock, plasma, pulmonary and hepatic increases in IL-6 and MCP-1 were observed along with inflammation and lung injury, which may culminate in acute respiratory distress syndrome [<xref rid="pntd.0007017.ref097" ref-type="bibr">97</xref>, <xref rid="pntd.0007017.ref098" ref-type="bibr">98</xref>, <xref rid="pntd.0007017.ref099" ref-type="bibr">99</xref>]. It is important to emphasize that in addition to cytokines, some other factors may be associated with the pulmonary hemorrhaging and death caused by a venom overdose. Further, the hemostatic alterations promoted by SVMP, SVSP and PLA<sub>2</sub> can also contribute to lung hemorrhage.</p><p>The treatment indicated for envenomation by <italic>N</italic>. <italic>annulifera</italic> is serum therapy. <italic>N</italic>. <italic>annulifera</italic> venom is part of the antigenic mixture used for the production of polyvalent serum by the South African Vaccine Producers (SAVP) (Pty) Ltd [<xref rid="pntd.0007017.ref028" ref-type="bibr">28</xref>], although its immunogenicity and neutralizing potential have been poorly investigated. Here, we show that <italic>N</italic>. <italic>annulifera</italic> venom is highly immunogenic in murine model. Although with different intensities, this mouse antivenom was able to recognize venom components by Western Blot, mainly the ones with high molecular weight, which includes components as HYA, LAAO, CVF and SVMP. Moreover, this monovalent antivenom was able to protect the animals from death induced by venom, with high potency. In contrast, other studies have shown that horse antivenoms produced against venom mixtures, in which <italic>N</italic>. <italic>annulifera</italic> was included, were not able to neutralize the lethal effects of this venom [<xref rid="pntd.0007017.ref056" ref-type="bibr">56</xref>, <xref rid="pntd.0007017.ref100" ref-type="bibr">100</xref>, <xref rid="pntd.0007017.ref101" ref-type="bibr">101</xref>]. This may be due to differences related to the animals used (mouse <italic>versus</italic> horse) or to a low level of neutralizing antibodies generated by other venoms present in the immunization pool.</p><p>In conclusion, here, we show that <italic>N</italic>. <italic>annulifera</italic> snake venom contains several components with toxic and pro-inflammatory properties. Some of these toxins promote coagulation disturbances, local and systemic inflammatory reactions, which may contribute to the pathologic events, observed in our murine model and possibly in dogs and humans envenomated by <italic>N</italic>. <italic>annulifera</italic>. Moreover, the venom promoted lung haemorrhage, an event that may also occur in cases of human envenomation, since death by respiratory arrest can be the result of the sum of neurotoxin activity and lung haemorrhage. High levels of IL-6 and MCP-1, as detected in the plasma of the envenomated animals, may be associated with pulmonary damage, since systemic inflammatory conditions can be deleterious and affect several organs, including the lungs. Thus, inflammation may be considered as target for the development of new therapeutic strategies in cases of <italic>N</italic>. <italic>annulifera</italic> human envenomation. Moreover, we showed that the venom is highly immunogenic and that the experimental serum was able to neutralize its lethal activity in the murine model. These data encourage further studies to characterize and produce monospecific therapeutic antivenom against <italic>N</italic>. <italic>annulifera</italic>.</p></sec><sec sec-type="supplementary-material" id="sec045"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0007017.s001"><label>S1 Table</label><caption><title>Identification of proteins in <italic>N. annulifera</italic> snake venom by trypsin digestion and LC-MS/MS analysis.</title><p>(XLSX)</p></caption><media xlink:href="pntd.0007017.s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007017.s002"><label>S2 Table</label><caption><title>Identification of protein families in <italic>N. annulifera</italic> snake venom by trypsin digestion and LC-MS/MS analysis.</title><p>(XLSX)</p></caption><media xlink:href="pntd.0007017.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007017.s003"><label>S1 Spectra</label><caption><title>Unique peptides identified in the <italic>N. annulifera</italic> snake venom.</title><p>(DOCX)</p></caption><media xlink:href="pntd.0007017.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007017.s004"><label>S1 Fig</label><caption><title>Pharmacologic modulation of the edema induced by <italic>N. annulifera</italic> snake venom.</title><p>To evaluate the contribution of the different inflammatory mediators classes in hindpaw edema induced by <italic>N</italic>. <italic>annulifera</italic>&#x02019; s venom, Balb/c mice groups were treated with [A] Cromolyn, a mast cell degranulation inhibitor (10 mg/kg, three days consecutively before the edema, i.p. route); [B] dexamethasone (Dexa), a cPLA<sub>2</sub> inhibitor (2 mg/kg, 2 hours before the edema, i.p. route); [C] indomethacin (Indo), a COX isoform inhibitor (10 mg/kg, 30 minutes before the edema, i.p. route); [D] MK886, a 5-lipoxygenase-activating protein inhibitor (5 mg/kg, 30 minutes before the edema, i.p. route) and [E] WEB2086, a PAFR antagonist (5 mg/kg, 1 hour before the edema, s.c. route). After treatment, edema was induced, and the paws were measured with a caliper rule at several time points. The increased paw volume was expressed as percentage. Statistical analysis was performed using two-way ANOVA, followed by the Bonferroni multiple comparison test (***<italic>p&#x02264;</italic> 0.05) &#x000b1; SD.</p><p>(TIF)</p></caption><media xlink:href="pntd.0007017.s004.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pntd.0007017.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Guti&#x000e9;rrez</surname><given-names>JM</given-names></name>, <name><surname>Theakston</surname><given-names>RDG</given-names></name>, <name><surname>Warrel</surname><given-names>DA</given-names></name>. (<year>2006</year>) <article-title>Confronting the neglected problem of snake bite envenoming: the need for a global partnership</article-title>. <source>PloS Med</source>
<volume>3</volume>:<fpage>150</fpage>.</mixed-citation></ref><ref id="pntd.0007017.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Kasturiratne</surname><given-names>A</given-names></name>, <name><surname>Wickremasinghe</surname><given-names>AR</given-names></name>, <name><surname>de Silva</surname><given-names>N</given-names></name>, <name><surname>Gunawardena</surname><given-names>NK</given-names></name>, <name><surname>Pathmeswaram</surname><given-names>A</given-names></name>, <name><surname>Premaratna</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The global burden of snakebite: a literature analysis and modeling based on regional estimates of envenoming and deaths</article-title>. <source>PloS Med</source>
<volume>5</volume>: <fpage>218</fpage>.</mixed-citation></ref><ref id="pntd.0007017.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Harrison</surname><given-names>RA</given-names></name>, <name><surname>Guti&#x000e9;rrez</surname><given-names>JM</given-names></name>. (<year>2016</year>) <article-title>Priority actions and progress to substantially and sustainably reduce the mortality, morbidity and socioeconomic burden of tropical snakebite</article-title>. <source>Toxins</source>
<volume>24</volume>: <fpage>1</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref004"><label>4</label><mixed-citation publication-type="other">The Reptile Database. Species number. 2018 [accessed Oct 18, 2018]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.reptile-database.org/db-info/SpeciesStat.html">http://www.reptile-database.org/db-info/SpeciesStat.html</ext-link></mixed-citation></ref><ref id="pntd.0007017.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>KS</given-names></name>, <name><surname>Dart</surname><given-names>RC</given-names></name>, <name><surname>Barish</surname><given-names>RA</given-names></name>. (<year>2002</year>) <article-title>Bites of venomous snakes</article-title>. <source>N Engl J Med</source>.</mixed-citation></ref><ref id="pntd.0007017.ref006"><label>6</label><mixed-citation publication-type="book"><name><surname>Pough</surname><given-names>FH</given-names></name>, <name><surname>Janis</surname><given-names>CM</given-names></name>, <name><surname>Heiser</surname><given-names>JB</given-names></name>. <source>A vida dos vertebrados</source>. <edition>4<sup>th</sup> ed</edition>
<publisher-loc>S&#x000e3;o Paulo</publisher-loc>: <publisher-name>Atheneu</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pntd.0007017.ref007"><label>7</label><mixed-citation publication-type="other">The Reptile Database. Higher taxa in extant reptiles. 2018 [accessed Oct 18, 2018]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.reptile-database.org/db-info/taxa.html">http://www.reptile-database.org/db-info/taxa.html</ext-link></mixed-citation></ref><ref id="pntd.0007017.ref008"><label>8</label><mixed-citation publication-type="other">The Reptile Database. Higher taxa: Elapidae. 2018 [accessed Oct 18, 2018]. Available from: <ext-link ext-link-type="uri" xlink:href="http://reptile-database.reptarium.cz/advanced_search?taxon=Elapidae&#x00026;submit=Search">http://reptile-database.reptarium.cz/advanced_search?taxon=Elapidae&#x00026;submit=Search</ext-link></mixed-citation></ref><ref id="pntd.0007017.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Slowinski</surname><given-names>JB</given-names></name>, <name><surname>Knight</surname><given-names>A</given-names></name>, <name><surname>Rooney</surname><given-names>AP</given-names></name>. (<year>1997</year>) <article-title>Inferring species trees from trees: a phylogenetic analysis of the Elapidae (Serpentes) based on the amino acid sequences of venom proteins</article-title>. <source>Mol Phylogenet Evol</source>
<volume>8</volume>: <fpage>349</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1006/mpev.1997.0434</pub-id>
<?supplied-pmid 9417893?><pub-id pub-id-type="pmid">9417893</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Phui Yee</surname><given-names>JS</given-names></name>, <name><surname>Nanling</surname><given-names>G</given-names></name>, <name><surname>Afifiyan</surname><given-names>F</given-names></name>, <name><surname>Donghui</surname><given-names>M</given-names></name>, <name><surname>Siew Lay</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Snake postsynaptic neurotoxins: gene structure, phylogeny and applications in research and therapy</article-title>. <source>Biochimie</source>
<volume>86</volume>: <fpage>137</fpage>&#x02013;<lpage>149</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Tytgat</surname><given-names>J</given-names></name>, <name><surname>Vanderbeghe</surname><given-names>I</given-names></name>, <name><surname>Ulens</surname><given-names>C</given-names></name>, <name><surname>Beeumen</surname><given-names>JV</given-names></name>. (<year>2001</year>) <article-title>New polypeptide components purified from mamba venom</article-title>. <source>FEBS Lett</source>
<volume>491</volume>: <fpage>282</fpage>&#x02013;<lpage>283</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Takacs</surname><given-names>Z</given-names></name>, <name><surname>Wilhelmsen</surname><given-names>KC</given-names></name>, <name><surname>Sorota</surname><given-names>S</given-names></name>. (<year>2004</year>) <article-title>Cobra (<italic>Naja spp</italic>) nicotinic acetylcholine receptor exhibits resistance to erabu sea snake (Laticauda semifasciata) short-chain &#x003b1;- neurotoxin</article-title>. <source>J Mol Evol</source>
<volume>58</volume>: <fpage>516</fpage>&#x02013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1007/s00239-003-2573-8</pub-id>
<?supplied-pmid 15170255?><pub-id pub-id-type="pmid">15170255</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>NH</given-names></name>, <name><surname>Tan</surname><given-names>CSA</given-names></name>. (<year>1988</year>) <article-title>A comparative study of cobra (<italic>Naja</italic>) venom enzymes</article-title>. <source>Comp Biochem Physiol</source>
<volume>90</volume>: <fpage>745</fpage>&#x02013;<lpage>750</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Petras</surname><given-names>D</given-names></name>, <name><surname>Sanz</surname><given-names>L</given-names></name>, <name><surname>Segura</surname><given-names>A</given-names></name>, <name><surname>Herrera</surname><given-names>M</given-names></name>, <name><surname>Villalta</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan- african echitab-plus-ICP antivenom by antivenomics and neutralization approaches</article-title>. <source>J Proteome Res</source>
<volume>10</volume>: <fpage>1266</fpage>&#x02013;<lpage>1280</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>GD</given-names></name>, <name><surname>Furtado</surname><given-names>MFD</given-names></name>, <name><surname>Portaro</surname><given-names>FCV</given-names></name>, <name><surname>Sant&#x02019;anna</surname><given-names>OA</given-names></name>, <name><surname>Tambourgi</surname><given-names>DV</given-names></name>. (<year>2010</year>) <article-title>Diversity of <italic>Micrurus</italic> snake species related to their venom toxic effects and the prospective of antivenom neutralization</article-title>. <source>Plos Negl Trop Dis</source>
<volume>4</volume>: <fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>GD</given-names></name>, <name><surname>Pidde-Queiroz</surname><given-names>G</given-names></name>, <name><surname>Furtado</surname><given-names>MFD</given-names></name>, <name><surname>Van Den Berg</surname><given-names>C</given-names></name>, <name><surname>Tambourgi</surname><given-names>D</given-names></name>. (<year>2012</year>) <article-title><italic>Micrurus</italic> snake venoms activate human complement system and generate anaphylatoxins</article-title>. <source>BCM Immunol</source>
<volume>13</volume>: <fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Malih</surname><given-names>I</given-names></name>, <name><surname>Ahmad Rusmili</surname><given-names>MR</given-names></name>, <name><surname>Tee</surname><given-names>TY</given-names></name>, <name><surname>Saile</surname><given-names>R</given-names></name>, <name><surname>Ghalim</surname><given-names>N</given-names></name>, <name><surname>Othman</surname><given-names>I</given-names></name>. (<year>2014</year>) <article-title>Proteomic analysis of Moroccan cobra <italic>Naja haje legionis</italic> venom using tandem mass spectrometry</article-title>. <source>J Proteomics</source>
<volume>16</volume>: <fpage>240</fpage>&#x02013;<lpage>252</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Vejayan</surname><given-names>J</given-names></name>, <name><surname>Khoon</surname><given-names>TL</given-names></name>, <name><surname>Ibrahim</surname><given-names>H</given-names></name>. <article-title>Comparative analysis of the venom proteome of four Malaysian snake species</article-title>. <source>J Venom Anim Toxins Incl Trop Dis</source>
<volume>20</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/1678-9199-20-1</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Oyama</surname><given-names>E</given-names></name>, <name><surname>Takashi</surname><given-names>H</given-names></name>. (<year>2006</year>) <article-title>Distribuition of low molecular weight platelet aggregation inhibitors from snake venoms</article-title>. <source>Toxicon</source>
<volume>49</volume>: <fpage>293</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2006.09.027</pub-id>
<?supplied-pmid 17141819?><pub-id pub-id-type="pmid">17141819</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Shweitz</surname><given-names>H</given-names></name>, <name><surname>Vigne</surname><given-names>P</given-names></name>, <name><surname>Moinier</surname><given-names>D</given-names></name>, <name><surname>Frelin</surname><given-names>C</given-names></name>, <name><surname>Lazdunski</surname><given-names>M</given-names></name>. (<year>1992</year>) <article-title>A new member of the natriuretic peptide family is present in the venom of the green mamba (<italic>Dendroaspis angusticeps</italic>)</article-title>. <source>J Biol Chem</source>
<volume>267</volume>: <fpage>13928</fpage>&#x02013;<lpage>13932</lpage>. <?supplied-pmid 1352773?><pub-id pub-id-type="pmid">1352773</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Tonsing</surname><given-names>L</given-names></name>, <name><surname>Potgieter</surname><given-names>DJJ</given-names></name>, <name><surname>Louw</surname><given-names>AI</given-names></name>, <name><surname>Visser</surname><given-names>L</given-names></name>. (<year>1983</year>) <article-title>The binding of snake venom cardiotoxins to heart cell membranes</article-title>. <source>Biochimt Biophysa Acta</source>
<volume>732</volume>: <fpage>282</fpage>&#x02013;<lpage>288</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Konshina</surname><given-names>AG</given-names></name>, <name><surname>Boldyrev</surname><given-names>IA</given-names></name>, <name><surname>Utkin</surname><given-names>YN</given-names></name>, <name><surname>Omel&#x02019;kov</surname><given-names>AV</given-names></name>, <name><surname>Efremov</surname><given-names>RG</given-names></name>. (<year>2011</year>) <article-title>Snake cytotoxins bind to membranes via interactions with phosphatidylserine head groups of lipids</article-title>. <source>Plos One</source>
<volume>6</volume>: <fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref023"><label>23</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>Guidelines for the prevention and clinical management of snakebite in &#x000c1;frica</source>. <publisher-loc>Brazaville</publisher-loc>: <publisher-name>World Health Organization Regional Office for Africa</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="pntd.0007017.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Mendez</surname><given-names>I</given-names></name>, <name><surname>Guti&#x000e9;rrez</surname><given-names>JM</given-names></name>, <name><surname>&#x000c2;ngulo</surname><given-names>Y</given-names></name>, <name><surname>Calvete</surname><given-names>JJ</given-names></name>, <name><surname>Lomonte</surname><given-names>B</given-names></name>. (<year>2011</year>) <article-title>Comparative study of the cytolytic activity of snake venoms African spitting cobras (<italic>Naja</italic> spp., Elapidae) and its neutralization by a polyspecific antivenom</article-title>. <source>Toxicon</source>
<volume>58</volume>: <fpage>558</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2011.08.018</pub-id>
<?supplied-pmid 21924279?><pub-id pub-id-type="pmid">21924279</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Berling</surname><given-names>I</given-names></name>, <name><surname>Brown</surname><given-names>SGA</given-names></name>, <name><surname>Miteff</surname><given-names>F</given-names></name>, <name><surname>Levi</surname><given-names>C</given-names></name>, <name><surname>Isbister</surname><given-names>GK</given-names></name>. (<year>2015</year>) <article-title>Intracranial haemorrhages associated with Venom induced consumption coagulophaty in Australian snakebites</article-title>. <source>Toxicon</source>
<volume>102</volume>: <fpage>8</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2015.05.012</pub-id>
<?supplied-pmid 26003794?><pub-id pub-id-type="pmid">26003794</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Tambourgi</surname><given-names>DV</given-names></name>, <name><surname>Santos</surname><given-names>MC</given-names></name>, <name><surname>Furtado</surname><given-names>MFD</given-names></name>, <name><surname>Freitas</surname><given-names>MCW</given-names></name>, <name><surname>Silva</surname><given-names>WD</given-names></name>, <name><surname>Kipnis</surname><given-names>TL</given-names></name>. (<year>1994</year>) <article-title>Pro-inflammatory activities in elapid snake venoms</article-title>. <source>Br J Pharmacol</source>
<volume>112</volume>: <fpage>723</fpage>&#x02013;<lpage>727</lpage>. <?supplied-pmid 7921595?><pub-id pub-id-type="pmid">7921595</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Cher</surname><given-names>CDN</given-names></name>, <name><surname>Armugam</surname><given-names>A</given-names></name>, <name><surname>Lachumanan</surname><given-names>R</given-names></name>, <name><surname>Coghlan</surname><given-names>MW</given-names></name>, <name><surname>Jeyaseelan</surname><given-names>K</given-names></name>. (<year>2003</year>) <article-title>Pulmonary inflammation and edema induced by Phospolipase A2: Global gene analysis on aquaporins and Na+/K+-ATPase</article-title>. <source>J Biol Chem</source>
<volume>278</volume>: <fpage>31352</fpage>&#x02013;<lpage>31360</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M302446200</pub-id>
<?supplied-pmid 12746451?><pub-id pub-id-type="pmid">12746451</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Dong</surname><given-names>VL</given-names></name>, <name><surname>Quyen</surname><given-names>LK</given-names></name>, <name><surname>Eng</surname><given-names>KH</given-names></name>, <name><surname>Gopalakrishnakone</surname><given-names>P</given-names></name>. (<year>2003</year>) <article-title>Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection</article-title>. <source>J Immunol Methods</source>
<volume>282</volume>: <fpage>13</fpage>&#x02013;<lpage>31</lpage>. <?supplied-pmid 14604537?><pub-id pub-id-type="pmid">14604537</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Koen</surname><given-names>TL</given-names></name>, <name><surname>Williams</surname><given-names>D</given-names></name>. (<year>2011</year>) <article-title>Snake antivenoms in southern Africa</article-title>. <source>C M E</source>
<volume>29</volume>: <fpage>75</fpage>&#x02013;<lpage>79</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Broadley</surname><given-names>DG</given-names></name>, <name><surname>W&#x000fc;ster</surname><given-names>W</given-names></name>. (<year>2004</year>) <article-title>A review of the southern African &#x0201c;<italic>non spitting</italic>&#x0201d; cobras (Serpentes: Elapidae: <italic>Naja</italic>)</article-title>. <source>African J Herpet</source>
<volume>53</volume>: <fpage>101</fpage>&#x02013;<lpage>122</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref031"><label>31</label><mixed-citation publication-type="other">Clinical Toxinology Resource. Snakes Search Page; 2018 [accessed Oct 18 2018]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.toxinology.com/fusebox.cfm?fuseaction=main.snakes.display&#x00026;id=SN0231">http://www.toxinology.com/fusebox.cfm?fuseaction=main.snakes.display&#x00026;id=SN0231</ext-link></mixed-citation></ref><ref id="pntd.0007017.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Eangelbrecht</surname><given-names>A</given-names></name>. (<year>2012</year>) <article-title>Management of common animal bites in the emergency centre: The most common animal bites to present in emergencies are dog and snake bites</article-title>. <source>Continuing Medical Education</source>
<volume>30</volume>: <fpage>401</fpage>&#x02013;<lpage>406</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Westrin</surname><given-names>L</given-names></name>, <name><surname>Von Rahmel</surname><given-names>P</given-names></name>. (<year>2011</year>) <article-title>The Snouted Cobra, <italic>Naja annulifera</italic>, Peters 1854</article-title>. <source>Berus</source>
<volume>6</volume>: <fpage>1</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Lobetti</surname><given-names>RG</given-names></name>, <name><surname>Joubert</surname><given-names>K</given-names></name>. (<year>2004</year>) <article-title>Retrospective study of snake envenomation in 155 dogs from the onderstepoort area of South Africa</article-title>. <source>J S Afr Vet Assoc</source>
<volume>75</volume>: <fpage>169</fpage>&#x02013;<lpage>172</lpage>. <?supplied-pmid 15830600?><pub-id pub-id-type="pmid">15830600</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Langhorn</surname><given-names>R</given-names></name>, <name><surname>Persson</surname><given-names>F</given-names></name>, <name><surname>Ablad</surname><given-names>B</given-names></name>, <name><surname>Goddard</surname><given-names>A</given-names></name>, <name><surname>Schoeman</surname><given-names>JP</given-names></name>, <name><surname>Willesen</surname><given-names>JL</given-names></name>, <name><surname>Tarnow</surname><given-names>I</given-names></name>, <name><surname>Kejelgaard-Hansen</surname><given-names>M</given-names></name>. (<year>2014</year>) <article-title>Myocardial injury in dogs with snake envenomation and its relation to systemic inflammation</article-title>. <source>J Vet Emerg Crit Care (San Antonio)</source>
<volume>24</volume>: <fpage>1006</fpage>&#x02013;<lpage>1010</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Nagel</surname><given-names>SS</given-names></name>, <name><surname>Schoeman</surname><given-names>JP</given-names></name>, <name><surname>Thompson</surname><given-names>P N</given-names></name>, <name><surname>Wiinberg</surname><given-names>B</given-names></name>, <name><surname>Goddard</surname><given-names>A</given-names></name>. (<year>2014</year>) <article-title>Hemostatic analysis of dogs naturally envenomed by the African Puffader (<italic>Bitis arietans</italic>) and Snouted Cobra (<italic>Naja annulifera</italic>)</article-title>. <source>J Vet Emerg Crit Care (San Antonio)</source>
<volume>24</volume>: <fpage>662</fpage>&#x02013;<lpage>671</lpage>.<pub-id pub-id-type="pmid">25351524</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Weise</surname><given-names>KHK</given-names></name>, <name><surname>Carlsson</surname><given-names>FHH</given-names></name>, <name><surname>Joubert</surname><given-names>FJ</given-names></name>, <name><surname>Strydom</surname><given-names>DJ</given-names></name>. (<year>1973</year>) <article-title>The purification of toxins V<sup>II</sup>1 and V<sup>II</sup>2, two cytotoxin homologues from banded egyptian cobra (<italic>Naja haje annulifera</italic>) venom, and the complete amino acid sequence of toxin V<sup>II</sup>1</article-title>. <source>Hoppe Seylers Z Physiol Chem</source>
<volume>354</volume>:<fpage>1317</fpage>&#x02013;<lpage>1326</lpage>. <?supplied-pmid 4803830?><pub-id pub-id-type="pmid">4803830</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Joubert</surname><given-names>FJ</given-names></name>. (<year>1975</year>) <article-title>The amino acid sequences of three toxins (CM-10, CM-12 and CM-14) from <italic>Naja haje annulifera</italic> (Egyptian Cobra) venom</article-title>. <source>Hoppe Seylers Z Physiol Chem</source>
<volume>356</volume>:0 <fpage>53</fpage>&#x02013;<lpage>72</lpage>. 1975.</mixed-citation></ref><ref id="pntd.0007017.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Joubert</surname><given-names>FJ</given-names></name>. (<year>1975</year>) <article-title>The amino acid sequences of toxin V<sup>II</sup>2, a cytotoxin homologue from banded egyptian cobra (<italic>Naja haje annulifera</italic>) venom</article-title>. <source>Hoppe Seylers Z Physiol Chem</source>
<volume>356</volume>: <fpage>1893</fpage>&#x02013;<lpage>1900</lpage>. <?supplied-pmid 1213684?><pub-id pub-id-type="pmid">1213684</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Joubert</surname><given-names>FJ</given-names></name>. (<year>1975</year>) <article-title>The purification and amino acid sequence of toxin CM-13b from <italic>Naja haje annulifera</italic> (Egyptian Cobra) venom</article-title>. <source>Hoppe Seylers Z Physiol Chem</source>
<volume>356</volume>: <fpage>1901</fpage>&#x02013;<lpage>1908</lpage>. <?supplied-pmid 1213685?><pub-id pub-id-type="pmid">1213685</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Joubert</surname><given-names>FJ</given-names></name>. (<year>1976</year>) <article-title>The amino acid sequences of three toxins (CM-8, CM-11 and CM-13a) from <italic>Naja haje annulifera</italic> (Egyptian Cobra) venom</article-title>. <source>Eur J Biochem</source>
<volume>64</volume>: <fpage>219</fpage>&#x02013;<lpage>232</lpage>. <?supplied-pmid 1278155?><pub-id pub-id-type="pmid">1278155</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Heus</surname><given-names>F</given-names></name>, <name><surname>Vonk</surname><given-names>F</given-names></name>, <name><surname>Otvos</surname><given-names>RA</given-names></name>, <name><surname>Bruyneel</surname><given-names>B</given-names></name>, <name><surname>Smit</surname><given-names>AB</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity</article-title>. <source>Toxicon</source>
<volume>61</volume>: <fpage>112</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2012.11.002</pub-id>
<?supplied-pmid 23159399?><pub-id pub-id-type="pmid">23159399</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Laemmli</surname><given-names>UK</given-names></name>. (<year>1970</year>) <article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title>. <source>Nature</source>
<volume>15</volume>: <fpage>680</fpage>&#x02013;<lpage>685</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Morrissey</surname><given-names>JH</given-names></name>. (<year>1980</year>) <article-title>Silver stain for proteins in polyacrilamide gels: a modified procedure with enhanced uniform sensitivity</article-title>. <source>Anal Bioch</source>
<volume>117</volume>: <fpage>307</fpage>&#x02013;<lpage>310</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Towbin</surname><given-names>H</given-names></name>, <name><surname>Staehelin</surname><given-names>T</given-names></name>, <name><surname>Gordon</surname><given-names>J</given-names></name>. (<year>1979</year>) <article-title>Eletrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications</article-title>. <source>PNAS</source>
<volume>76</volume>: <fpage>4350</fpage>&#x02013;<lpage>4354</lpage>. <?supplied-pmid 388439?><pub-id pub-id-type="pmid">388439</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Paix&#x000e3;o-Cavalcante</surname><given-names>D</given-names></name>, <name><surname>Kuniyoshi</surname><given-names>AK</given-names></name>, <name><surname>Portaro</surname><given-names>FC</given-names></name>, <name><surname>Da Silva</surname><given-names>WD</given-names></name>, <name><surname>Tambourgi</surname><given-names>DV</given-names></name>. (<year>2015</year>) <article-title>African adders: partial characterization of snake venoms from three <italic>Bitis</italic> species of medical importance and their neutralization by experimental equine antivenoms</article-title>. <source>Plos Negl Trop Dis</source>
<volume>9</volume>: <fpage>1</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref047"><label>47</label><mixed-citation publication-type="book"><name><surname>Kinter</surname><given-names>M</given-names></name>,<name><surname>Sherman</surname><given-names>NE</given-names></name>. <source>Protein sequencing and identification using tandem mass spectrometry</source>. <publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name>
<year>2000</year>: <fpage>161</fpage>&#x02013;<lpage>163</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Rappsilber</surname><given-names>J</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>, <name><surname>Ishihama</surname><given-names>Y</given-names></name>. (<year>2007</year>) <article-title>Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips</article-title>. <source>Nat Protoc</source>. <volume>2</volume>(<issue>8</issue>):<fpage>1896</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.261</pub-id>
<?supplied-pmid 17703201?><pub-id pub-id-type="pmid">17703201</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>J</given-names></name>. and <name><surname>Mann</surname><given-names>M</given-names></name>. (<year>2008</year>) <article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title>. <source>Nature Biotechnology</source>
<volume>26</volume>(<issue>12</issue>) <fpage>1367</fpage>&#x02013;<lpage>1372</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id>
<?supplied-pmid 19029910?><pub-id pub-id-type="pmid">19029910</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Vizca&#x000ed;no</surname><given-names>J.</given-names></name>; <name><surname>Deutsch</surname><given-names>E.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name> (<year>2014</year>) <article-title>ProteomeXchange provides globally coordinated proteomics data submission and dissemination</article-title>. <source>Nat. Biotechnol</source>. <volume>32</volume>, <fpage>223</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2839</pub-id>
<?supplied-pmid 24727771?><pub-id pub-id-type="pmid">24727771</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Heussen</surname><given-names>C</given-names></name>, <name><surname>Dowdle</surname><given-names>EB</given-names></name>. (<year>1980</year>) <article-title>Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates</article-title>. <source>Anal Biochem</source>
<volume>102</volume>: <fpage>196</fpage>&#x02013;<lpage>202</lpage>. <?supplied-pmid 7188842?><pub-id pub-id-type="pmid">7188842</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Pukrittayakamee</surname><given-names>S</given-names></name>, <name><surname>Warrell</surname><given-names>DA</given-names></name>, <name><surname>Desakorn</surname><given-names>V</given-names></name>, <name><surname>McMichael</surname><given-names>AJ</given-names></name>, <name><surname>White</surname><given-names>NJ</given-names></name>, <name><surname>Bunnag</surname><given-names>D</given-names></name>. (<year>1988</year>) <article-title>The hyaluronidase activities of some southeast asian snake venoms</article-title>. <source>Toxicon</source>
<volume>26</volume>: <fpage>629</fpage>&#x02013;<lpage>637</lpage>. <?supplied-pmid 3176052?><pub-id pub-id-type="pmid">3176052</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Mosmann</surname><given-names>T</given-names></name>. (<year>1980</year>) <article-title>Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title>. <source>J Immunol Methods</source>
<volume>65</volume>: <fpage>55</fpage>&#x02013;<lpage>63</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Gulati</surname><given-names>G</given-names></name>, <name><surname>Hevelow</surname><given-names>M</given-names></name>, <name><surname>George</surname><given-names>M</given-names></name>, <name><surname>Behling</surname><given-names>E</given-names></name>, <name><surname>Siegel</surname><given-names>J</given-names></name>. <article-title>International normalized ratio versus plasma levels of coagulation factors in patients on vitamin L antagonist therapy</article-title>. <source>Arch Pathol Lab Med</source>
<volume>135</volume>: <fpage>490</fpage>&#x02013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1043/2009-0474-OA.1</pub-id>
<?supplied-pmid 21466367?><pub-id pub-id-type="pmid">21466367</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Ramos-Cerrillo</surname><given-names>B</given-names></name>, <name><surname>De Roodt</surname><given-names>A</given-names></name>, <name><surname>Chippaux</surname><given-names>JP</given-names></name>, <name><surname>Olgu&#x000ed;n</surname><given-names>L</given-names></name>, <name><surname>Casasola</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers e elapids</article-title>. <source>Toxicon</source>
<volume>52</volume>: <fpage>881</fpage>&#x02013;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2008.09.002</pub-id>
<?supplied-pmid 18926842?><pub-id pub-id-type="pmid">18926842</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref056"><label>56</label><mixed-citation publication-type="book"><name><surname>Finney</surname><given-names>PJ</given-names></name>. <source>Probit Analysis</source>. <edition>3<sup>rd</sup> ed</edition>
<publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>; <year>1971</year>.</mixed-citation></ref><ref id="pntd.0007017.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Yamakawa</surname><given-names>M</given-names></name>, <name><surname>Nozaki</surname><given-names>M</given-names></name>, <name><surname>Hokama</surname><given-names>Z</given-names></name>. (<year>1976</year>) <article-title>Fractionation of sakishima habu (<italic>Trimeresurus elegans</italic>) venom and lethal hemorrhagic, and edema forming activities of fractions</article-title>. <source>In Animal plant and microbial toxins</source>
<volume>48</volume>: <fpage>97</fpage>&#x02013;<lpage>109</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Galv&#x000e3;o Nascimento</surname><given-names>N</given-names></name>, <name><surname>Sampaio</surname><given-names>MC</given-names></name>, <name><surname>Amaral Olivo</surname><given-names>R</given-names></name>, <name><surname>Teixeira</surname><given-names>C</given-names></name>. (<year>2010</year>) <article-title>Contribution of mast cells to the oedema induced by <italic>Bothrops moojeni</italic> snake venom and pharmacological assessment of the inflammatory mediator involved</article-title>. <source>Toxicon</source>
<volume>55</volume>: <fpage>343</fpage>&#x02013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2009.08.009</pub-id>
<?supplied-pmid 19703484?><pub-id pub-id-type="pmid">19703484</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Olivo</surname><given-names>R</given-names></name>, <name><surname>Teixeira</surname><given-names>CF</given-names></name>, <name><surname>Wallace</surname><given-names>JL</given-names></name>, <name><surname>Gutierrez</surname><given-names>JM</given-names></name>, <name><surname>Zamuner</surname><given-names>SR</given-names></name>. (<year>2007</year>) <article-title>Role of cyclooxigenases in oedema-forming activity of bothropic venoms</article-title>. <source>Toxicon</source>
<volume>49</volume>: <fpage>670</fpage>&#x02013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2006.11.006</pub-id>
<?supplied-pmid 17204299?><pub-id pub-id-type="pmid">17204299</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Wanderley</surname><given-names>CW</given-names></name>, <name><surname>Silva</surname><given-names>CM</given-names></name>, <name><surname>Wong</surname><given-names>DV</given-names></name>, <name><surname>Ximenes</surname><given-names>RM</given-names></name>, <name><surname>Morelo</surname><given-names>DF</given-names></name>, <name><surname>Coeker</surname><given-names>F</given-names></name>, <name><surname>Arag&#x000e3;o</surname><given-names>KS</given-names></name>, <name><surname>Fernandes</surname><given-names>C</given-names></name>, <name><surname>Palheta-J&#x000fa;nior</surname><given-names>RC</given-names></name>, <name><surname>Havt</surname><given-names>A</given-names></name>, <name><surname>Brito</surname><given-names>GA</given-names></name>, <name><surname>Cunha</surname><given-names>FQ</given-names></name>, <name><surname>Ribeiro</surname><given-names>RA</given-names></name>, <name><surname>Lima-J&#x000fa;nior</surname></name>. (<year>2014</year>) <article-title><italic>Bothrops jararacussu</italic> snake venom-induces a local inflammatory response in a prostanoid- and neutrophil-dependent manner</article-title>. <source>Toxicon</source>
<volume>90</volume>: <fpage>134</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2014.08.001</pub-id>
<?supplied-pmid 25127849?><pub-id pub-id-type="pmid">25127849</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Zoccal</surname><given-names>KF</given-names></name>, <name><surname>Sorgi</surname><given-names>CA</given-names></name>, <name><surname>Hori</surname><given-names>JI</given-names></name>, <name><surname>Paula-Silva</surname><given-names>FW</given-names></name>, <name><surname>Arantes</surname><given-names>EC</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Zamboni</surname><given-names>DS</given-names></name>, <name><surname>Faccioli</surname><given-names>LH</given-names></name>. (<year>2016</year>) <article-title>Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality</article-title>. <source>Nat Commun</source>
<volume>23</volume>: <fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Cirino</surname><given-names>G</given-names></name>, <name><surname>Peers</surname><given-names>SH</given-names></name>, <name><surname>Wallace</surname><given-names>JL</given-names></name>, <name><surname>Flower</surname><given-names>RJ</given-names></name>. (<year>1989</year>) <article-title>A study of phospholipase A<sub>2</sub>-induced oedema in rat paw</article-title>. <source>Eur J Pharmacol</source>
<volume>166</volume>: <fpage>505</fpage>&#x02013;<lpage>510</lpage>. <?supplied-pmid 2806373?><pub-id pub-id-type="pmid">2806373</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Koga</surname><given-names>MM</given-names></name>, <name><surname>Bizzarro</surname><given-names>B</given-names></name>, <name><surname>S&#x000e1;-Nunes</surname><given-names>A</given-names></name>, <name><surname>Rios</surname><given-names>JF</given-names></name>, <name><surname>Jancar</surname><given-names>S</given-names></name>. (<year>2016</year>) <article-title>Boosting adaptive immunity: A new role for PAFR antagonists</article-title>. <source>Sci Rep</source>
<volume>14</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Goldstein</surname><given-names>IJ</given-names></name>. (<year>1975</year>) <article-title>Studies on the combining sites of concanavalin A</article-title>. <source>Adv Exp Med Biol</source>
<volume>55</volume>: <fpage>35</fpage>&#x02013;<lpage>53</lpage>. <?supplied-pmid 1155247?><pub-id pub-id-type="pmid">1155247</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Kubota</surname><given-names>Y</given-names></name>, <name><surname>Fujiota</surname><given-names>K</given-names></name>, <name><surname>Takekawa</surname><given-names>M</given-names></name>. (<year>2017</year>) <article-title>WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins</article-title>. <source>PLoS One</source>
<volume>7</volume>: <fpage>1</fpage>&#x02013;<lpage>12</lpage></mixed-citation></ref><ref id="pntd.0007017.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Panagides</surname><given-names>N</given-names></name>, <name><surname>Jackson</surname><given-names>TN</given-names></name>, <name><surname>Ikonomopoulou</surname><given-names>MP</given-names></name>, <name><surname>Arbuckle</surname><given-names>K</given-names></name>, <name><surname>Pretzler</surname><given-names>R</given-names></name>, <name><surname>yang</surname><given-names>DC</given-names></name>, <name><surname>Ali</surname><given-names>SA</given-names></name>, <name><surname>Koludarov</surname><given-names>I</given-names></name>, <name><surname>Dobson</surname><given-names>J</given-names></name>, <name><surname>Sanker</surname><given-names>B</given-names></name>, <name><surname>Asselin</surname><given-names>A</given-names></name>, <name><surname>Santana</surname><given-names>RC</given-names></name>, <name><surname>Hendrikx</surname><given-names>I</given-names></name>, <name><surname>Van der Ploeg</surname><given-names>H</given-names></name>, <name><surname>Tai-A-Pin</surname><given-names>J</given-names></name>, <name><surname>Van den Bergh</surname><given-names>R</given-names></name>, <name><surname>Kerkkamp</surname><given-names>HM</given-names></name>, <name><surname>Vonk</surname><given-names>FJ</given-names></name>, <name><surname>Naude</surname><given-names>A</given-names></name>, <name><surname>Strydom</surname><given-names>MA</given-names></name>, <name><surname>Jacobsz</surname><given-names>L</given-names></name>, <name><surname>Dunstan</surname><given-names>N</given-names></name>, <name><surname>Jaeger</surname><given-names>M</given-names></name>, <name><surname>Hodgson</surname><given-names>WC</given-names></name>, <name><surname>Miles</surname><given-names>J</given-names></name>, <name><surname>Fry</surname><given-names>BG</given-names></name>. (<year>2017</year>) <article-title>How the cobra got its flesh-eating venom: Cytotoxicity as a defensive innovation and its co-evolutaion with hooding, aposematic marking, and spitting</article-title>. <source>Toxins (Basel)</source>
<volume>13</volume>: <fpage>1</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Ebrahim</surname><given-names>K</given-names></name>, <name><surname>Shirazi</surname><given-names>FH</given-names></name>, <name><surname>Mirakabadi</surname><given-names>AZ</given-names></name>, <name><surname>Vatanpour</surname><given-names>H</given-names></name>. (<year>2015</year>) <article-title>Cobra venom cytotoxins: apoptotic or necrotic agents</article-title>. <source>Toxicon</source>
<volume>108</volume>: <fpage>108</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2015.10.004</pub-id><pub-id pub-id-type="pmid">26472254</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Andrade-Silva</surname><given-names>D</given-names></name>, <name><surname>Zelanis</surname><given-names>A</given-names></name>, <name><surname>Kitano</surname><given-names>ES</given-names></name>, <name><surname>Junqueira-de-Azevedo</surname><given-names>IL</given-names></name>, <name><surname>Reis</surname><given-names>MS</given-names></name>, <name><surname>Lopes</surname><given-names>AS</given-names></name>, <name><surname>Serrano</surname><given-names>SM</given-names></name>. <article-title>Proteomic and glycoproteomic profilings reveal that post-translational modifications of toxins contribute to venom phenotype in snakes</article-title>. <source>J Proteome Res</source>. <year>2016</year>
<volume>15</volume>(<issue>8</issue>):<fpage>2658</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00217</pub-id>
<?supplied-pmid 27297130?><pub-id pub-id-type="pmid">27297130</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Zelanis</surname><given-names>A</given-names></name>, <name><surname>Serrano</surname><given-names>SM</given-names></name>, <name><surname>Reinhold</surname><given-names>VN</given-names></name>. (<year>2012</year>) <article-title>N-glycome profiling of <italic>Bothrops jararaca</italic> newborn and adults venoms</article-title>. <source>J Proteome Res</source>
<volume>75</volume>: <fpage>774</fpage>&#x02013;<lpage>782</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Zelanis</surname><given-names>A</given-names></name>, <name><surname>Tashima</surname><given-names>AK</given-names></name>, <name><surname>Rocha</surname><given-names>MM</given-names></name>, <name><surname>Furtado</surname><given-names>MF</given-names></name>, <name><surname>Camargo</surname><given-names>AC</given-names></name>, <name><surname>Serrano</surname><given-names>SM</given-names></name>. (<year>2010</year>) <article-title>Analysis of the ontogenetic variation in the venom proteome/peptidome of <italic>Bothrops jararaca</italic> reveals different strategies to deal with prey</article-title>. <source>J Proteome Res</source>
<volume>9</volume>: <fpage>2278</fpage>&#x02013;<lpage>2291</lpage>. <pub-id pub-id-type="doi">10.1021/pr901027r</pub-id>
<?supplied-pmid 20146532?><pub-id pub-id-type="pmid">20146532</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Fujita</surname><given-names>T</given-names></name>. (<year>2002</year>) <article-title>Evolution of the lectin-complement pathway and its role in innate immunity</article-title>. <source>Nat Rev Immunol</source>
<volume>2</volume>:<fpage>346</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1038/nri800</pub-id>
<?supplied-pmid 12033740?><pub-id pub-id-type="pmid">12033740</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Ricklin</surname><given-names>D</given-names></name>, <name><surname>Reis</surname><given-names>ES</given-names></name>, <name><surname>Lambris</surname><given-names>JD</given-names></name>. (<year>2016</year>) <article-title>Complement in disease: a defence system turning offensive</article-title>. <source>Nat Rev Nephrol</source>
<volume>12</volume>: <fpage>383</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2016.70</pub-id>
<?supplied-pmid 27211870?><pub-id pub-id-type="pmid">27211870</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Kang</surname><given-names>TS</given-names></name>, <name><surname>Georgieva</surname><given-names>D</given-names></name>, <name><surname>Genov</surname><given-names>N</given-names></name>, <name><surname>Murakami</surname><given-names>MT</given-names></name>, <name><surname>Sinha</surname><given-names>M</given-names></name>, <name><surname>Kumar</surname><given-names>RP</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Enzymatic toxins from snake venom: structural characterization and mechanisms of catalysis</article-title>. <source>FEBS J</source>
<volume>278</volume>:<fpage>4544</fpage>&#x02013;<lpage>4576</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08115.x</pub-id>
<?supplied-pmid 21470368?><pub-id pub-id-type="pmid">21470368</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>NH</given-names></name>, <name><surname>Tan</surname><given-names>CS</given-names></name>. (<year>1988</year>) <article-title>A comparative study of cobra (<italic>Naja</italic>) venom enzymes</article-title>. <source>Comp Biochem Physiol B</source>
<volume>90</volume>: <fpage>745</fpage>&#x02013;<lpage>750</lpage>. <?supplied-pmid 2854766?><pub-id pub-id-type="pmid">2854766</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>NH</given-names></name>, <name><surname>Ponnudurai</surname><given-names>G</given-names></name>. (<year>1992</year>) <article-title>The biological properties of venoms of some American coral snakes (Genus <italic>Micrurus</italic>)</article-title>. <source>Comp Biochem Physiol B</source>
<volume>101</volume>: <fpage>471</fpage>&#x02013;<lpage>474</lpage>. <?supplied-pmid 1582185?><pub-id pub-id-type="pmid">1582185</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>MA</given-names></name>, <name><surname>Waterman</surname><given-names>JM</given-names></name>, <name><surname>Du Plessis</surname><given-names>P</given-names></name>, <name><surname>Smit</surname><given-names>M</given-names></name>, <name><surname>Bennett</surname><given-names>NC</given-names></name>. (<year>2012</year>) <article-title>No evidence for proteolytic venom resistance in southern African ground squirrels</article-title>. <source>Toxicon</source>
<volume>60</volume>: <fpage>760</fpage>&#x02013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2012.06.004</pub-id>
<?supplied-pmid 22728461?><pub-id pub-id-type="pmid">22728461</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Kemparaju</surname><given-names>K</given-names></name>, <name><surname>Girish</surname><given-names>KS</given-names></name>. (<year>2006</year>) <article-title>Snake venom hyaluronidase: a therapeutic target</article-title>. <source>Cell Biochem Funct</source>
<volume>24</volume>: <fpage>7</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.1261</pub-id>
<?supplied-pmid 16245359?><pub-id pub-id-type="pmid">16245359</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Bitencourt</surname><given-names>CD</given-names></name>, <name><surname>Gelfuso</surname><given-names>GM</given-names></name>, <name><surname>Pereira</surname><given-names>PAT</given-names></name>, <name><surname>De Assis</surname><given-names>PA</given-names></name>, <name><surname>Tef&#x000e9;-Silva</surname><given-names>C</given-names></name>, <name><surname>Ramos</surname><given-names>SG</given-names></name>
<etal>et al</etal> (<year>2015</year>) <article-title>Hyaluronidase-Loaded PLGA Microparticles as a new strategy for the treatment of pulmonary fibrosis</article-title>. <source>Tissue Eng Part A</source>
<volume>21</volume>: <fpage>246</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEA.2013.0403</pub-id>
<?supplied-pmid 25037276?><pub-id pub-id-type="pmid">25037276</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>D</given-names></name>, <name><surname>Liang</surname><given-names>J</given-names></name>, <name><surname>Fan</surname><given-names>J</given-names></name>, <name><surname>Yu</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, Luo Y <etal>et al</etal> (<year>2005</year>) <article-title>Regulation of lung injury and repair by Toll-like receptors and hyaluronan</article-title>. <source>Nat Med</source>
<volume>11</volume>: <fpage>1173</fpage>&#x02013;<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.1038/nm1315</pub-id>
<?supplied-pmid 16244651?><pub-id pub-id-type="pmid">16244651</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Burke</surname><given-names>JE</given-names></name>, <name><surname>Dennis</surname><given-names>EA</given-names></name>. (<year>2009</year>) <article-title>Phospholipase A<sub>2</sub> structure/function, mechanisms, and signaling</article-title>. <source>J Lipid Res</source>
<volume>50</volume>: <fpage>237</fpage>&#x02013;<lpage>242</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Pirolla</surname><given-names>RAS</given-names></name>, <name><surname>Baldasso</surname><given-names>PA</given-names></name>, <name><surname>Marangoni</surname><given-names>S</given-names></name>, <name><surname>Moran</surname><given-names>PJ</given-names></name>, <name><surname>Rodrigues</surname><given-names>JAR</given-names></name>. (<year>2011</year>) <article-title>Evaluation of snake Venom Phospholipase A<sub>2</sub>: hydrolysis of non-natural esters</article-title>. <source>J Braz Chem Soc</source>
<volume>22</volume>: <fpage>300</fpage>&#x02013;<lpage>307</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Borges</surname><given-names>RJ</given-names></name>, <name><surname>Lemke</surname><given-names>N</given-names></name>, <name><surname>Fontes</surname><given-names>MRM</given-names></name>. (<year>2017</year>) <article-title>PLA2-like proteins myotoxic mechanism: a dynamic model description</article-title>. <source>Sci Rep. Nov 14</source>; <volume>7</volume>(<issue>1</issue>):<fpage>15514</fpage>.</mixed-citation></ref><ref id="pntd.0007017.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Leiguez</surname><given-names>E</given-names></name>, <name><surname>Giannotti</surname><given-names>KC</given-names></name>, <name><surname>Moreira</surname><given-names>V</given-names></name>, <name><surname>Matsubara</surname><given-names>MH</given-names></name>, <name><surname>Guti&#x000e9;rrez</surname><given-names>JM</given-names></name>, <name><surname>Lomonte</surname><given-names>B</given-names></name>, <name><surname>Rodr&#x000ed;guez</surname><given-names>JP</given-names></name>, <name><surname>Balsinde</surname><given-names>J</given-names></name>, <name><surname>Teixeira</surname><given-names>C</given-names></name>. (<year>2014</year>) <article-title>Critical role of TLR2 and MyD88 for functional response of macrophages to a group IIA-secreted phospholipase A2 from snake venom</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref084"><label>84</label><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>KY</given-names></name>, <name><surname>Tan</surname><given-names>CH</given-names></name>, <name><surname>Tan</surname><given-names>KY</given-names></name>, <name><surname>Quraishi</surname><given-names>NH</given-names></name>, <name><surname>Tan</surname><given-names>NH</given-names></name>. (<year>2018</year>) <article-title>Elucidating the biogeographical variation of the venom of <italic>Naja naja</italic> (spectacled cobra) from Pakistan through a venom-decomplexing proteomic study</article-title>. <source>J Proteomics</source>
<volume>175</volume>: <fpage>153</fpage>&#x02013;<lpage>173</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref085"><label>85</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>KY</given-names></name>, <name><surname>Tan</surname><given-names>CH</given-names></name>, <name><surname>Fung</surname><given-names>SY</given-names></name>, <name><surname>Tan</surname><given-names>NH</given-names></name>. (<year>2015</year>) <article-title>Venomics, lethality and neutralization of <italic>Naja kaouthia</italic> (monocloned cobra) venoms from three different geographical regions of Southeast Asia</article-title>. <pub-id pub-id-type="doi">10.1016/j.jprot.2015.02.012</pub-id>
<?supplied-pmid 25748141?><pub-id pub-id-type="pmid">25748141</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref086"><label>86</label><mixed-citation publication-type="journal"><name><surname>Lauridsen</surname><given-names>LP</given-names></name>, <name><surname>Laustsen</surname><given-names>AH</given-names></name>, <name><surname>Lomonte</surname><given-names>B</given-names></name>, <name><surname>Guti&#x000e9;rrez</surname><given-names>JM</given-names></name>. (<year>2016</year>) <article-title>Exploring the venom of the forest cobra: Toxicovenomics and antivenom profiling of <italic>Naja melanoleuca</italic></article-title>. <source>J Proteomics</source>
<volume>150</volume>: <fpage>98</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2016.08.024</pub-id>
<?supplied-pmid 27593527?><pub-id pub-id-type="pmid">27593527</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref087"><label>87</label><mixed-citation publication-type="journal"><name><surname>Malih</surname><given-names>I</given-names></name>, <name><surname>Rusmili</surname><given-names>MRA</given-names></name>, <name><surname>Tee</surname><given-names>TY</given-names></name>, <name><surname>Saile</surname><given-names>R</given-names></name>, <name><surname>Ghalim</surname><given-names>N</given-names></name>, <name><surname>Othman</surname><given-names>I</given-names></name>. (<year>2014</year>) <article-title>Proteomic analysis of Moroccan cobra <italic>Naja haje legionis</italic> venom using tandem mass spectrometry</article-title>. <source>J Proteomics</source>
<volume>96</volume>: <fpage>2040</fpage>&#x02013;<lpage>251</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref088"><label>88</label><mixed-citation publication-type="journal"><name><surname>Sim&#x000f5;es de Oliveira</surname><given-names>PR</given-names></name>, <name><surname>Fran&#x000e7;a</surname><given-names>FS</given-names></name>, <name><surname>Villas Boas</surname><given-names>IM</given-names></name>, <name><surname>Teixeira da Rocha</surname><given-names>MM</given-names></name>, <name><surname>Sant&#x02019;Anna</surname><given-names>SS</given-names></name>, <name><surname>Bastos</surname><given-names>ML</given-names></name>, <name><surname>Tambourgi</surname><given-names>DV</given-names></name>. (<year>2018</year>) <article-title>Snake venoms from Angola: Intra-specific variations and immunogenicity</article-title>. <source>Toxicon</source>
<volume>148</volume>: <fpage>85</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2018.04.013</pub-id>
<?supplied-pmid 29673703?><pub-id pub-id-type="pmid">29673703</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref089"><label>89</label><mixed-citation publication-type="journal"><name><surname>Stefansson</surname><given-names>S</given-names></name>, <name><surname>Kini</surname><given-names>RM</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>. (<year>1989</year>) <article-title>The inhibition of clotting complexes of the extrinsic cascade by the phospholipase A<sub>2</sub> isoenzymes from <italic>Naja nigricollis</italic> venom</article-title>. <source>Thromb Res</source>
<volume>15</volume>: <fpage>481</fpage>&#x02013;<lpage>491</lpage>. J Proteomics 120: 105&#x02013;173.</mixed-citation></ref><ref id="pntd.0007017.ref090"><label>90</label><mixed-citation publication-type="journal"><name><surname>Stefansson</surname><given-names>S</given-names></name>, <name><surname>Kini</surname><given-names>RM</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>. (<year>1990</year>) <article-title>The basic phospholipase A<sub>2</sub> from <italic>Naja nigricollis</italic> venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism</article-title>. <source>Biochemistry</source>
<volume>21</volume>: <fpage>7742</fpage>&#x02013;<lpage>7746</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref091"><label>91</label><mixed-citation publication-type="journal"><name><surname>Kini</surname><given-names>RM</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>. (<year>1995</year>) <article-title>The role of enzymatic activity in inhibition of the extrinsic tenase complex by phospholipase A<sub>2</sub> isoenzymes from <italic>Naja nigricollis</italic> venom</article-title>. <source>Toxicon</source>
<volume>33</volume>: <fpage>1585</fpage>&#x02013;<lpage>1590</lpage>. <?supplied-pmid 8866616?><pub-id pub-id-type="pmid">8866616</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref092"><label>92</label><mixed-citation publication-type="journal"><name><surname>Kerns</surname><given-names>RT</given-names></name>, <name><surname>Kini</surname><given-names>RM</given-names></name>, <name><surname>Stefansson</surname><given-names>S</given-names></name>, <name><surname>Evans</surname><given-names>HJ</given-names></name>. (<year>1999</year>) <article-title>Targeting of venom phospholipase: the strongly anticoagulant Phospholipase A<sub>2</sub> from <italic>Naja nigricollis</italic> venom binds to coagulation factor Xa to inhibit the protrombinase complex</article-title>. <source>Arch Biochem Biophys</source>
<volume>369</volume>: <fpage>107</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1999.1345</pub-id>
<?supplied-pmid 10462445?><pub-id pub-id-type="pmid">10462445</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref093"><label>93</label><mixed-citation publication-type="journal"><name><surname>MacKay</surname><given-names>N</given-names></name>, <name><surname>Ferguson</surname><given-names>JC</given-names></name>, <name><surname>McNicol</surname><given-names>GP</given-names></name>. (<year>1969</year>) <article-title>Effects three cobra venoms on blood coagulation, platelet aggregation, and fibrinolysis</article-title>. <source>J clin Path</source>
<volume>22</volume>: <fpage>304</fpage>&#x02013;<lpage>311</lpage>. <?supplied-pmid 5814735?><pub-id pub-id-type="pmid">5814735</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref094"><label>94</label><mixed-citation publication-type="journal"><name><surname>White</surname><given-names>J</given-names></name>. <article-title>International symposium on coral snakes: Elapidae snakebite in Africa and Asia</article-title>. <year>2016</year> [accessed Oct 18, 2018]. Available from: <ext-link ext-link-type="uri" xlink:href="http://sites.pucgoias.edu.br/eventos/isc/wp-content/uploads/sites/34/2016/10/anais_miolo-1.pdf">http://sites.pucgoias.edu.br/eventos/isc/wp-content/uploads/sites/34/2016/10/anais_miolo-1.pdf</ext-link></mixed-citation></ref><ref id="pntd.0007017.ref095"><label>95</label><mixed-citation publication-type="journal"><name><surname>Ali</surname><given-names>SA</given-names></name>, <name><surname>Alam</surname><given-names>JM</given-names></name>, <name><surname>Abbasi</surname><given-names>A</given-names></name>, <name><surname>Zaidi</surname><given-names>ZH</given-names></name>, <name><surname>Stoeva</surname><given-names>S</given-names></name>, <name><surname>Voelter</surname><given-names>W</given-names></name>. (<year>2000</year>) <article-title>Sea snake <italic>Hydrophis cyanocinctus</italic> venom. II. Histopathological changes, induced by a myotoxic phospholipase A<sub>2</sub> (PLA<sub>2</sub>-H1)</article-title>. <source>Toxicon</source>
<volume>38</volume>: <fpage>687</fpage>&#x02013;<lpage>705</lpage>. <?supplied-pmid 10673160?><pub-id pub-id-type="pmid">10673160</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref096"><label>96</label><mixed-citation publication-type="journal"><name><surname>Ownby</surname><given-names>CL</given-names></name>, <name><surname>Fletcher</surname><given-names>JE</given-names></name>, <name><surname>Colberg</surname><given-names>TR</given-names></name>. (<year>1993</year>) <article-title>Cardiotoxin 1 from cobra (<italic>Naja naja atra</italic>) venom causes necrosis of skeletal muscle in vivo</article-title>. <source>Toxicon</source>
<volume>31</volume>: <fpage>697</fpage>&#x02013;<lpage>709</lpage>. <?supplied-pmid 8342169?><pub-id pub-id-type="pmid">8342169</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref097"><label>97</label><mixed-citation publication-type="journal"><name><surname>Hierholzer</surname><given-names>C</given-names></name>, <name><surname>Kalff</surname><given-names>JC</given-names></name>, <name><surname>Laurel</surname><given-names>O</given-names></name>, <name><surname>Katsuhiko</surname><given-names>T</given-names></name>, <name><surname>Loeffert</surname><given-names>JE</given-names></name>, <name><surname>Watkins</surname><given-names>SC</given-names></name>, <name><surname>Billiar</surname><given-names>TR</given-names></name>, <name><surname>Tweardy</surname><given-names>DJ</given-names></name>. (<year>1998</year>) <article-title>Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury</article-title>. <source>Am J Physiol</source>
<volume>275</volume>: <fpage>611</fpage>&#x02013;<lpage>621</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref098"><label>98</label><mixed-citation publication-type="journal"><name><surname>Frink</surname><given-names>M</given-names></name>, <name><surname>Lu</surname><given-names>A</given-names></name>, <name><surname>Thobe</surname><given-names>BM</given-names></name>, <name><surname>Hsieh</surname><given-names>YC</given-names></name>, <name><surname>Choudhry</surname></name>, <name><surname>Shwacha</surname><given-names>MG</given-names></name>, <name><surname>Kunkel</surname><given-names>SL</given-names></name>, <name><surname>Chaudry</surname><given-names>IH</given-names></name>. (<year>2006</year>) <article-title>Monocyte chemoattractant protein-1 influences trauma-hemorrhage-induced distal organ damage via regulation of keratinocyte-derived chemokine production</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>
<volume>292</volume>: <fpage>1110</fpage>&#x02013;<lpage>1116</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref099"><label>99</label><mixed-citation publication-type="journal"><name><surname>Mommsen</surname><given-names>P</given-names></name>, <name><surname>Barkhausen</surname><given-names>T</given-names></name>, <name><surname>Frink</surname><given-names>M</given-names></name>, <name><surname>Zeckey</surname><given-names>C</given-names></name>, <name><surname>Probst</surname><given-names>C</given-names></name>, <name><surname>Krettek</surname><given-names>C</given-names></name>, <name><surname>Hildebrand</surname><given-names>F</given-names></name>. (<year>2011</year>) <article-title>Productive capacity of alveolar macrophages and pulmonar organ damage after femoral fracture and hemorrhage in IL-6 knockout mice</article-title>. <source>Cytokine</source>
<volume>53</volume>: <fpage>60</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2010.09.005</pub-id>
<?supplied-pmid 20934884?><pub-id pub-id-type="pmid">20934884</pub-id></mixed-citation></ref><ref id="pntd.0007017.ref100"><label>100</label><mixed-citation publication-type="journal"><name><surname>Guidolin</surname><given-names>FR</given-names></name>, <name><surname>Caricati</surname><given-names>CP</given-names></name>, <name><surname>Marcelino</surname><given-names>JR</given-names></name>, <name><surname>Da Silva</surname><given-names>WD</given-names></name>. (<year>2016</year>) <article-title>Development of equine IgG antivenoms against major snake groups in Mozambique</article-title>. <source>PLoS Negl Trop Dis</source>
<volume>10</volume>: <fpage>1</fpage>&#x02013;<lpage>17</lpage>.</mixed-citation></ref><ref id="pntd.0007017.ref101"><label>101</label><mixed-citation publication-type="journal"><name><surname>S&#x000e1;nchez</surname><given-names>A</given-names></name>, <name><surname>Segura</surname><given-names>A</given-names></name>, <name><surname>Vargas</surname><given-names>M</given-names></name>, <name><surname>Herrera</surname><given-names>M</given-names></name>, <name><surname>Villalta</surname><given-names>M</given-names></name>, <name><surname>Estrada</surname><given-names>R</given-names></name>, <name><surname>Wu</surname><given-names>F</given-names></name>, <name><surname>Litschka-Koen</surname><given-names>T</given-names></name>, <name><surname>Perry</surname><given-names>MA</given-names></name>, <name><surname>Alape-Gir&#x000f3;n</surname><given-names>A</given-names></name>, <name><surname>Le&#x000f3;n</surname><given-names>G</given-names></name>. (<year>2017</year>) <article-title>Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa</article-title>. <source>Toxicon</source>
<volume>125</volume>: <fpage>59</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2016.11.259</pub-id>
<?supplied-pmid 27890775?><pub-id pub-id-type="pmid">27890775</pub-id></mixed-citation></ref></ref-list></back></article>